Get Adobe Flash player

MECHANISMS OF STIMULATION OF PHYSICAL PERFORMANCE UNDER INFLUENCE OF ANTIOXIDANT PHARMACOLOGICAL AGENTS (REVIEW)

Authors: Gunina L. M.

Pages: 1-14

Abstract


Introduction. The enhancement of the general and special physical workabilities of sportsmen under the influence of significant physical loads and under conditions of the fast course of the processes of rehabilitation and the prevention of the state of overtraining are the important components for the realization of the sportsman as a professional and for the support of his/her health and life quality. One of the very weighty factors in the appearance of an overstrain and in a decrease of the physical workability is the activation of the lipid peroxidation at the simultaneous damping of the activity of the endogenous antioxidant system, which accompanies permanently the physical loads and causes the development of such pathobiochemical and pathophysiological phenomenon as the oxidative stress. On the level of a holistic organism, the damping of the activity of enzymatic systems (first of all, antioxidative ones) under the action of physical loads prolongs the period of rehabilitation after trainings and complicates the formation of a necessary level of adaptation mechanisms inherent in sportsmen. It is clear that, at high-intensity physical loads, there is a necessity to use antioxidant pharmacological preparations that are not forbidden. A large number of such preparations available at the modern sport-pharmaceutical market do not allow a physician to independently clarify the mechanisms of action of certain preparations or dietary additives on the physical workability. This leads to the groundless use of several preparations together and can be accompanied by the appearance of their cross interaction and by secondary effects. One of the ways to solve this complicated task is the application of antioxidant preparations of the metabolitotropic character.

Purpose – to determine the fine mechanisms of effect of pharmacological preparations with antioxidant directivity on the physical workability.

Materials and Methods. Analysis and generalization of data of the modern scientific literature, the Internet, and author’s own results of studies.

Discussion. The study showed that presented survey of the literature generalizes the ways of participation of natural antioxidants in the formation of a metabolic basis of the physical workability of sportsmen. It is shown that one of the main system-forming factors that hamper an increase in the physical workability is the oxidative stress mediated by loads of the training. This is related to the fact that the distortion of a structural-functional state of cell membranes, particularly the membranes of erythrocytes, due to the oxidative stress causes the changes in their shape and volume, which affects mediately the process of oxygen transport to the muscular tissue of sportsmen and, thus, decreases the physical workability. The antioxidant properties of the studied pharma-cological preparations of the natural origin and the metabolitotropic character are related to the presence of a membranotropic action, which allows one to refer the preparations with such biological effects to ergogenic ones. The executed analysis has clarified the mechanisms of influence of the pharmacological preparations with antioxidant properties such as ceruloplasmin, omega-3-polyunsaturated fatty acids, and probiotic products on components of the process of stimulation of the physical workability. It is shown that, along with the direct antioxidant action, the presence of membranotropic (membranoprotective), detoxifying, immuno- and cardioprotective actions, etc. is of great importance for the manifestation of ergogenic properties of a pharmacological preparation. It is proved that the influence of the indicated factors, which participate in the formation of metabolic foundations of the physical workability and are related to the presence of the antioxidant effect for organism, can be associated with other various complex changes in the homeostasis of organism, by starting from the exhaustion of the stores of ATP in cells and the accumulation of catecholamines to the expression of genetic markers of the mitochondrial biogenesis and the apoptosis of cells. Based on the results of the executed analysis, we may consider that the various mechanisms inherent in pharmacological antioxidant preparations of the mainly metabolitotropic character must be taken into account at their prescription to sportsmen on various stages of the training process.

Keywords: exercise, oxidative stress, antioxidant agents, structural and functional state of cell membranes, detoxic properties, cardiotropic effect.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

1. Gonchar OO, Yakovleva IYu, OlIynik SA. [Effect of yakton on prooxidant-antioxidant balance under hypoxic conditions]. Sportivna meditsina. 2005;(2):110  117. 
2. Gunina LM. [Effect of sodium succinate in red blood cells by oxidative stress during intense exercise]. Physiol. J. 2011;56(6):71–79.
3. Stephens FB, Greenhaff PL. Metabolic limitations to performance. The Olympic textbook of science in sport; Ed. by Maughan RJ. Wiley-Blackwell, 2009. pp. 324–339.
4. Fisher-Wellman K, Bloomer RJ. Acute exercise and oxidative stress: a 30 year history. Dyn. Med. 2009;8:1–12.
5. Deminice R, Sicchieri T, Mialich MS, Milani F, Ovidio PP, Jordao AA. Oxidative stress biomarker responses to an acute session of hypertrophy-resistance traditional interval training and circuit training. J. Strength Cond. Res. 2011;25(3):798–804.
6. Volchegorskiy IA, Shaposhnik II, Aleks EN, Harchenkova NV. [Content of lipid peroxidation products and ceruloplasmin in the blood as an indicator of exercise tolerance in hypertrophic cardiomyopathy]. Klinicheskaya laboratornaya diagnostika. 2002;(2):11–13.
7. Statsenko EA, Kovkova AV, Nehay EV. [Development of a new marker of fitness athletes]. Voprosy kurortologii, fizioterapii, lechebnoy fizkulturyi. 2012;(3):42–45.
8. Statsenko EA. [Characteristics of lipid peroxidation and markers of endogenous intoxication in monitoring physical loads during rower training]. Voprosy kurortologii, fizioterapii, lechebnoy fizkulturyi. 2011;(3):41–45.
9. Wang J-S, Huang Y-H. Effects of exercise intensity on lymphocyte apoptosis induced by oxidative stress in men. Eur. J. Appl. Physiol. 2005;(95):290–291.
10. Kozirev AV, Tsebrzhinskiy OI. [Antioxidants as a means of improving physical performance in athletes vesluvalnykiv during the recovery period]. Sportivna nauka Ukrayini. 2010;(3):3–10. 
11. Hüttemann M, Lee I, Perkins GA, Britton SL, Koch LG, Malek MH. (-)-Epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity. Clin. Sci. (Lond). 2013;124(11):663–674.
12. Mazur IA, Chekman IS, Belenichev IF. Metabolytnye preparaty [Metaboliс medical drugs]. Zaporozhe, 2007. 309 р.
13. Chekman IS, Gorchakova NA, Frantsuzova SB, Nagornaya EA. Metabolitnyie i metabolitotropnyie preparatyi v sisteme kardio- i organoprotektsii [Metaboliс and metabolitotropic drugs in the system of cardio- and organoprotection]. Кiev, 2009. 155 p.
14. Gunina LM, OlIshevskiy SV, Petrik PV. [Effect of metabolic polyprotektor Cardonat on the performance of special fitness and homeostasis in weightlifting qualifications]. Liki Ukrayini. 2010;4 (140):83–88. 
15. Zapata-Sudo G, Lima LM, Pereira SL, Trachez MM, da Costa FP, Souza B J, Monteiro CE, Romeiro NC, D'Andrea ÉD, Sudo RT, Barreiro EJ. Docking, synthesis and anti-diabetic activity of novel sulfonylhydrazone derivatives designed as PPAR-gamma agonists. Curr. Top. Med. Chem. 2012;12(19):2037–2048.
16. Gunina LM, Nosach OV. [Metabolic aspects of the impact of physical activity: oxidative stress and adaptation]. Ukraynsky zhurnal klinichnoyi ta laboratornoyi meditsini. 2012;4:237–243.
17. Lyahov OM, Gunina LM, Oliynik SA. [Investigation of the mechanisms of interaction of ceruloplasmin with monolayer lamina of dystearoyilphosphatydyl-choline]. Ukr. biohim. J. 2007;79(3):97–100.
18. Gunina LM. [Relationship of aggregation properties of erythrocytes membranes' structural and functional state and physical performance of athletes at oxidative stress]. Krovoobig ta gemostaz. 2010;(3):15–18. 
19. Gunina LM, Chekman IS, Nebesna TYu, Gorchakova NO. [Quantum-chemical properties analysis and evaluation of the usefulness of omega-3 polyunsaturated fatty acids by physical activity]. Physiol. J. 2013;59(1):68–77
20. Bryant JW, Shariat-Madar Z. Human plasma kallikrein-kinin system: physiological and biochemical parameters. Cardiovasc. Hematol. Agents Med. Chem. 2009;7(3):234–250.
21. Schweitzer GG, Cartee GD. Postexercise skeletal muscle glucose transport is normal in kininogen-deficient rats. Med. Sci. Sports Exerc. 2011;43(7):1148–1153.
22. Donde A, Wong H, Frelinger J, Power K, Balmes JR, Arjomandi M. Effects of exercise on systemic inflammatory, coagulatory, and cardiac autonomic parameters in an inhalational exposure study. Occup. Environ. Med. 2012;54(4):466–470.
23. Luneva OG, Brazhe NA, Fadyukova OE, Ahalaya MYu, Bayzhumanov AA, Parshina EYu, Demidova AE, Koshelev VB, Maksimov GV. [The role of the plasma in the erythrocyte membrane formation of hypoxia in patients with chronic heart failure]. Terapevtichesky archiv. 2005;77(9):70–73.
24. Rajasekar P1, Balasaraswathi K, Anuradha CV. Effects of L-carnitine on RBC membrane composition and function in hyperinsulinemic rats. Ital. J. Biochem. 2007;56(1):53–60.
25. Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ. Deformation-induced ATP release from red blood cells requires CFTR activity. Am. J. Physiol. 1998;275(Pt 52):H 1726–1732.
26. Gunina LM. [Red blood cells by oxidative stress during exercise (review)]. Perspektivi meditsini ta biologiji. 2013;5(1):7–13.
27. Dufour SP Patel RP, Brandon A, Teng X, Pearson J, Barker H, Ali L, Yuen AH, Smolenski RT, González-Alonso J. Erythrocyte-dependent regulation of human skeletal muscle blood flow: role of varied oxyhemoglobin and exercise on nitrite, S-nitrosohemoglobin, and ATP. Am. J. Physiol. Heart. Circ. Physiol. 2010;299(6):1936–1946.
28. Babenko L, Gunina L, Oleynik S. [Investigation of antioxidant action and genomoprotektive ergogenic drugs in vitro]. Nauka v olimpiyskom sporte. 2006;(2):37–39.
29. Gunina Larysa M, Chekman Ivan S, Nebesna TetyanaYu, Gorchakova Nadia O. Efficiency of ω-3 Polyunsaturated Fatty Acids at Physical Exercise. Int. J. Physiol. Pathophysiol. 2013;4(Iss. 4):273–283.
30. Gunina LM, Oliynik SA, Ivanov SV. [Biochemical as well as structural and functional properties of the membranes of red blood cells and anemia in athletes]. Physiol. J. 2007;53(3):43–50.
31. Teległów A, Dabrowski Z, Marchewka A, Tabarowski Z, Bilski J, Jaśkiewicz J. Effects of cold water swimming on blood rheological properties and composition of fatty acids in erythrocyte membranes of untrained older rats. Folia Biol. (Krakow). 2011;59(3-4):203–209.
32. Clifford M, Scalbert A. Ellagitanins – nature, occurrence and dietary burden. J. Sci. Food. Agric. 2000;80(7):1118–1125.
33. Berdinskih NK, Kurischuk KV, Lyalyushko NM, Lyadska LS. Ceruloplasmin: funkcyi v organisme, farmakologicheskye svoystva i primenenie v klinicheskoy praktike [Ceruloplasmin: the functions in the body, pharmacological properties and use in clinical practice]. – Kiev: Prosvita Publ., 2001. 41 p.
34. Bento I, Peixoto C, Zaitsev VN, Lindley PF. Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites. Acta Cryst. 2007;63:240248.
35. Oshiro S, Kawamura K, Zhang C. Microglia and astroglia prevent oxidative stress-induced neuronal cell death: implications for aceruloplasminemia. Biochim. Biophys. Acta. 2008;1782(2):109117.
36. Hawley JA. Adaptations of skeletal muscle to prolonged, intense endurance training. Clin. Exp. Pharmacol. Physiol. 2002;29(3)218–222.
37. Ahalaya MYu, Platonov AG, Bayzhumanov AA. [Short-term cold exposure improves antioxidant status and the total resistance of the animals]. Bulleten' eksperimental'noy biologii i mediziny. 2006;141(1):26–29.
38. Kenyon CL, Basaraba RJ, Bohn AA. Influence of endurance exercise on serum concentrations of iron and acute phase proteins in racing sled dogs. J. Am. Vet. Med. Assoc. 2011;239(9):1201–1210.
39. Sheremetev YuA, Popovicheva AN, Egorihina MN, Levin GYa. [А study of the relationship between the change in shape and aggregation of human erythrocytes]. Biofizika. 2013;58( 2)264–268.
40. Din Jehangir N, Sarma Jaydeep, Harding Scott A, Lyall Karin, Newby David E, Flapan Andrew D. Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trial. BMJ Open. 2013;3(9):e003054.
41. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans. J. Lipid. Res. 2009;40:785–807.
42. Feschenko YuI, Gavrisyuk VK. Omega-3 PNZhK. Novyiy lekarstvennyiy preparat Tekom [Omega-3 PUFAs. New medical drug Tecom]. Kiev, 1996. 124 p.
43. Ramel A, Martinez JA, Kiely M, Bandarra NM, Thorsdottir I. Moderate consumption of fatty fish reduces diastolic blood pressure in overweight and obese. European young adults during energy restriction. Nutrition. 2010;26(2)168–174.
44. Bondarenko VM. [Polykomponent Probiotics: Mechanism of action and terapevtic effect in intestinal dysbiosis]. Farmateka. 2005;115(20):46–54.
45. Balla E, Dicks LM, Toit du M. Characterization and cloning of the genes encoding enterocin 1071A and enterocin 1071B, two antimicrobial peptides produced by Enterococcus faecalis BFE1071. Appl. Envir. Microbiol. 2000;66:1298–1304.
46. Creti R, Imperi M, Bertuccini L. Survey for virulence among Enterococcus faecalis isolated from different sources. J. Med. Microbiol. 2004;53:13–20. 
47. Kolodjieva V, Yafaev R, Yermolenko E, Suvorov A. Incidence of virulence determinants in enterococcal strains of probiotic and clinical origin. New Insights Into and Old Enemy. N.-J., 2006. pp. 367–370.
48. Тarasova E, Yermolenko E, Donets V, Sundukova Z, Bochkareva A, Borshev I, Suvorova M, Ilyasov I, Simanenkov V, Suvorov AN. The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics. Benef. Microbes. 2010;1(3):265–270.
49. Peters EM. Nutritional aspects in ultra-endurance exercise. Review. Curr. Opin. Clin. Nutr. Metab. Care. 2003;6(4):427–434.
50. Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J. Am. Coll. Cardiol. 2014;63(14):1345–1354.
51. Eliason EJ, Clark TD, Hinch SG, Farrell AP. Cardiorespiratory performance and blood chemistry during swimming and recovery in three populations of elite swimmers: Adult sockeye salmon. Comp. Biochem. Physiol. Mol. Integr. Physiol. 2013;166(2):385–397.
52. Karanth J, Jeevaratnam K. Oxidative stress and antioxidant status in rat blood, liver and muscle: effect of dietary lipid, carnitine and exercise. Int. J. Vitam. Nutr. Res. 2005;75(5):333–339.
53. Antonova N., Riha P., Ivanov I., Gluhcheva Y. Experimental evaluation of mechanical and electrical properties of RBC suspensions in Dextran and PEG under flow II. Role of RBC deformability and morphology. Clin. Hemorheol. Microcirc. 2011;49(1-4):441–450.
54. Forsyth AM, Braunmüller S, Wan J, Franke T, Stone HA. The effects of membrane cholesterol and simvastatin on red blood cell deformability and ATP release. Microvasc Res. 2012;83(3):347–351.
55. González-Alonso J. ATP as a mediator of erythrocyte-dependent regulation of skeletal muscle blood flow and oxygen delivery in humans. J. Physiol. 2012;590(Pt 20):5001–5013.
56. Tokarska-Schlattner M, Epand RF, Meiler F. Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects. PLoS One.2012;7(8):e43178.
57. Weinberg JA, MacLennan PA, Vandromme-Cusick MJ. The deleterious effect of red blood cell storage on microvascular response to transfusion. J. Trauma Acute Care Surg. 2013;75(5):807–812.
58. Ghonaim NW, Ghonaim NW, Fraser GM, Ellis CG, Yang J, Goldman D. Modeling steady state SO2-dependent changes in capillary ATP concentration using novel O2 micro-delivery methods. Front. Physiol. 2013;4(260):321–329.
59. Zingman LV, Zhu Z, Sierra A. Exercise-induced expression of cardiac ATP-sensitive potassium channels promotes action potential shortening and energy conservation. J. Mol. Cell Cardiol. 2011;51(1):72–81. 
60. Zhu Z, Sierra A, Burnett CM. Sarcolemmal ATP-sensitive potassium channels modulate skeletal muscle function under low-intensity workloads. J. Gen. Physiol. 2014;143(1):119–134.
61. Psilander N, Wang L, Westergren J, Tonkonogi M, Sahlin K. Mitochondrial gene expression in elite cyclists: effects of high-intensity interval exercise. Eur. J. Appl. Physiol. 2010;110(3):597–606.
62. Jamart C, Benoit N, Raymackers JM. Autophagy-related and autophagy-regulatory genes are induced in human muscle after ultraendurance exercise. Eur. J. Appl. Physiol. 2012;112(8):3173–3177.
63. Gunina L.M. [Evaluating the effectiveness of probiotic functional food "Laminolakt Sporting" during intense physical exertion]. Problemi ekologichnoyi ta medichnoyi genetiki i klinichnoyi imunologiyi: Zbirka naukovych prats. 2012;6(114):334–342.
64. Takala TE, Kiviluoma K, Ihlström M, Rämö P, Vihko V. Effects of physical training, methandione and their combination on the lysosomal hydrolytic activities in dog heart. Int. J. Med. Sports. 1992;13(1):52–55.
65. Mila-Kierzenkowska C, Woźniak A, Szpinda M. Effects of thermal stress on the activity of selected lysosomal enzymes in blood of experienced and novice winter swimmers. Scand. J. Clin. Lab. Invest. 2012;72(8):635–641.
66. Wygrecka M, Markart P, Fink L, Guenther A, Preissner KT. Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS). Thorax. 2007;62(10):880–888.
67. Gerondopoulos A, Langemeyer L, Liang JR, Linford A, Barr FA. BLOC-3 mutated in Hermansky-Pudlak syndrome is a Rab32/38 guanine nucleotide exchange factor. Curr. Biol. 2012;22(2):2135–2139.
68. Velez JC, Ierardi JL, Bland AM. Enzymatic processing of angiotensin peptides by human glomerular endothelial cells. Am. J. Physiol. Renal. Physiol. 2012;302(12):F1583–1594.
69. Ribeiro J, Almeida-Dias A, Ascensão A. Hemostatic response to acute physical exercise in healthy adolescents. J. Sci. Med. Sport. 2007;10(3):164–169.
70. Chen TH, Yang YC, Wang JC, Wang JJ. Curcumin treatment protects against renal ischemia and reperfusion injury-induced cardiac dysfunction and myocardial injury. Transplant. Proc. 2013;45(10):3546–3549.
71. Hsu CC, Wang JJ. L-ascorbic acid and alpha-tocopherol attenuates liver ischemia-reperfusion induced of cardiac function impairment. Transplant. Proc. 2012;44(4):933–936.
72. Schwedhelm E, Maas R, Troost R, Böger RH. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin. Pharmacokinet. 2003;42(5):437–459.
73. Zenkov NK, Lankin VZ, Menshikova EB. Okislitelnyiy stress. Biohimicheskiy i patofiziologicheskiy aspektyi [Oxidative stress. Biochemical and pathophysiological aspects]. Moskva: MAIK-Nauka Interperiodika Publ., 2001. 265 p.
74. Barandier C, Tanguy S, Pucheu S. Effect of antioxidant trace elements on the response of cardiac tissue to oxidative stress. Ann. N.-Y. Acad. Sci. 1999;874:138–155.
75. Ashraf J, Roshan VD. Is short-term exercise a therapeutic tool for improvement of cardioprotection against DOX-induced cardiotoxicity? An experimental controlled protocol in rats. Asian Pac. J. Cancer Prev. 2012;13(8):4025–4030.
76. Hidirova LD. [Changing the balance between the activity of lipid peroxidation, antioxidant protection and the content of iron in rats with experimental myocardial infarction]. Ratsionalnaya farmakoterapiya v kardiologii. 2010;6(2):216–219.
77. Chen Y, McMillan-Ward E, Kong J, Israels SJ, Gibson SB. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008;15(1):171–182.
78. Magenta A, Cencioni C, Fasanaro P. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death. Differ. 2011;18(10):1628–1639.
79. Park MY, Jeong YJ, Kang GC, Kim MH, Kim SH, Chung HJ, JungJY, Kim WJ. Nitric oxide-induced apoptosis of human dental pulp cells is mediated by the mitochondria-dependent pathway. Korean J. Physiol. Pharmacol. 2014;18(1): 25–32.
80. Liu WY, He W. Exhaustive training increases uncoupling protein 2 expression and decreases Bcl-2/Bax ratio in rat skeletal muscle. Oxid. Med. Cell Longev. 2013(3):780719.
81. Vandenabeele P, Berghe T, Vanden A, Festjens N. Caspase inhibitors promote alternative cell death pathways. Sci STKE. 2006;(358):44.
82. Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, Kwon D, Jun K, Zheng D, Sievers R, Angeli F, Yeghiazarians Y, Lee R. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp. Gerontol. 2011;46(7):549–559.
83. Picatoste B, Ramírez E, Caro-Vadillo A. Sitagliptin reduces cardiac apoptosis, hypertophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms. PLoS One. 2013; (10):e78330.
84. Gavrilova EA, Zemtsovskiy EV. [Sudden cardiac death and myocardial hypertrophy in athletes]. Vestnik aritmologiji. 2010;(62):59–61.
85. Siu PM, Bryner RW, Martyn JK, Alway SE. Apoptotic adaptations from exercise training in skeletal and cardiac muscles. FASEB J. 2004;18(10):1150–1152.
86. Leandro CG, Ribeiro da Silva W, Dos Santos JA, Bento-Santos А, Lima-Coelho CH, Falcão-Tebas F, Lagranha CJ, Lopes-de-Souza S, Manhães-de-Castro R, Toscano AE. Moderate physical training attenuates muscle-specific effects on fibre type composition in adult rats submitted to a perinatal maternal low-protein diet. Eur. J. Nutr. 2011;11(4):123–134.
87. Friedmann-Bette B, Schwartz FR, Eckhardt H. Similar changes of gene expression in human skeletal muscle after resistance exercise and multiple fine needle biopsies. J. Appl. Physiol. 2012;112(2):289–295.

 

HEREDITARY MOTOR-SENSORY NEUROPATHY: EPIDEMIOLOGICAL, CLINICAL AND GENETIC ASPECTS

Authors: Hovbaкh I.A.

Pages: 15-24

Abstract


Introduction. The epidemiological, clinical-genetic aspects of hereditary motor-sensory neuropathy (HMSN) have been considered in the article. HMSN are the heterogeneous group of hereditary diseases characterized by the injury of the axon and myelin sheath of peripheral nerves; HMSN manifest a marked significant clinical polymorphism with a broad distinction of phenotype; different type of inheritance; features of the clinical course, electroneuromyographic and morfohistochemical changes; chronic slowly progressive course.

NMSN epidemiologyis characterized by a broad prevalence in all world populations and makes up ranging from 10 to 40 morbid events by 100 000 people with significant differences in distinct populations. The basic NMSN clinical manifestations are muscle weakness and atrophy, predominantly in the distal lower extremities, extending as far as disease development in the distal upper extremities; moderate decrease in sensitivity; changing of the foot shape; gradual onset and slow progress with the development of significant defect within 1-2 decades. At the present more than 29 genes in which mutations lead to HMSN development have been identified. According to the classification by Dyck PJ and Lambert EH 7 types of NMSN are specified. Taking in account conduction velocity (СV) in motor fibers of the median nerve in accordance with Harding and Thomas NMSN types are distinguished: 1) demyelinating (SV <38 m/s); 2) axonal (SV > 38 m/s) 3) intermediate (SV 25-45 m/s).

Discussion. In consideration of that at the present NMSN pathogenetic therapy methods have not been developed early diagnosis and disease prevention in following generations have great important in disease prevention that causes the necessity of their further study and refinement of an integrated clinical and genetic testing of this disease.

Keywords: hereditary motor-sensory neuropathy, epidemiology, clinical manifestations, genetic polymorphism, inheritance patterns.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Dyck P. J., Chance P. F., Lebo R., Carney J. A. Hereditary motor and sensory neuropathies // Peripheral neuropathy. 3 ed. Philadelphia, 1993. P. 1094–1136.
  2. Emery A. E. H. Population frequencies of inherited neuromuscular diseases: a world survey // Neuromusc. Disord. 1991. Vol. 103. P. 19–29.
  3. Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME: Charcot-Marie-Tooth disease subtypes and genetic testing strategies. Ann Neurol 2011, 69:22-33.
  4. ttp://www.neuro.wustl.edu/neuromuscular/time/hmsn.html. Neuromuscu lar Disease Center.
  5. Chance P. F., Fischbeck K. H. Molecular genetics of Charcot – Mari – Tooth disease and related neuropathies // Hum. Mol. Genet. 1994. Vol. 3. P. 1503–1507.
  6. Bienfait H., Baas F., Koelman J. et al. Phenotype of Charcot-Marie-Tooth disease Type 2. Neurology 2007; 68: 1658—1667.
  7. Harding A. E., Thomas P. K. The clinical features of hereditary motor and sensory neuropathy types I and II // Brain. 1980. Vol. 103, № 2. P. 259–280.
  8. Birouk N., Azzedine H., Dubourg O. et al. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. Arch Neurol 2003; 60: 4: 598—604.
  9. Vallat J.M., Grid D., Magdelaine C. et al. Autosomal recessive forms of Charcot-Marie-Tooth disease. Curr Neurol Neurosci Rep 2004; 4: 5: 413— 419
  10. http://www.molgen.ua.ac.be/CMTMutations/DataSource/MutByGene. cfm. CMT mutation data base.
  11. Nelis E., Erdem S., Van Den Bergh P.Y. et al. Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology 2002; 59: 12: 1865—1872.
  12. De Sandre-Giovannoli A., Chaouch M., Boccaccio I. et al. Phenotypic and genetic exploration of severe demyelinating and secondary axonal neuropathies resulting from GDAP1 nonsense and splicing mutations. JMedGenet 2003; 40: 7: e87.

 

PATHOMORPHOLOGICAL CHANGES OF RENAL CORPUSCLE IN THE LATE STAGES OF CHRONIC OPIOID EFFECT

Authors: Vilkhova I.V., Paltov E.V., Kryvko Y.Y., Kyryk K.A., Demikhova N.V.

Pages: 25-31

Abstract


The aim of conducted study was to identify the morphological changes of renal corpuscle as a result of chronic effect of low opioid doses. The research subjects consisted of 32 mature male albino (Wistar) rats, weighting 160 to 170 gm and 4.5 to 5.5 months of age. The chronic opioid effect model was created. Intramuscular injection of nalbuphine was made once daily between 10am and 11am for a period of 98 days with a 0.212 mg/kg of primary dose and its gradual increase within acceptable therapeutic range. Histological preparations were made by a universal method. All animals were kept in vivarium conditions and the work was done according to “Guide for the Use of Laboratory Animals”. Structural changes of renal corpuscle were identified on eighth, tenth, twelfth and fourteenth week of chronic opioid use. As a result of long-termed exposure to low doses of nalbuphine intense alteration of renal corpuscles was discovered, such as segmental glomerulosclerosis and mesengial glomerular inflammation. The most intense changes were observed in renal corpuscles of subcapsular zone, where sclerosis of the majority of renal corpuscles, focal lymphohistiocytic infiltration and replacement of the necrotic area with the connective tissue were revealed.

Isolated sclerosed glomeruli, increased number of mesangial cells and proliferation of endotheliocytes were discovered in intercortical and juxtamedullary renal corpuscles. In some renal corpuscles, capillary loops were fused with outer capsular leaf, connective tissue fibers of Bowman’s capsule outer leaf were proliferated, and swollen cubic epitheliocytes were observed. The most intense changes of animal renal corpuscles were revealed in the end of fourteenth week of the study.

Keywords: renal corpuscle, opioid analgesic, rat, morphology, histological research, segmental glomerulosclerosis.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

1. Syvolap YuP, Savchenkov VA [Abuse of opioids and opioid dependence] М.6 «Medicine», 2005. – 304 p. (In Russian).
2. Pyatnitskaya IN [Addiction as a social and general medical problem]. Rosiiskiy Medicinskiy Zhurnal [Russian Medical Journal]. 1996:№ 4:5-10. (In Russian).
3. Sudakov SK [Individual predisposition to opiate addiction. Experimental studies] М.: «Narco-net». 2002:96. (In Ukrainian).
4. Linsky IV, Goludchikov IV, Minko OI [Recent trends of dependence on psychoactive substances in Ukraine. Analytical Review]. Issue 3. Kharkiv. 2006: 46. (In Russian).
5. Pigolkin YuI, Bogomolov DV [Morphological changes of the internal organs in opium addiction]. Archiv patologii [Archives of Pathology]. 2002:1:3-5. (In Russian).
6. Pigolkin YuI, Gasanov AV [Comparative morphological characteristics of immune deficiency in opiate addiction and chronic alcohol intoxication]. Sudebnaya meditsinskaya expertisa [Forensic Medical Expertise]. 2010:53(1):26-29. (In Russian).
7. Shabanov PD, Shtakelberg OYu [Drug addiction: pathopsychology, clinic, rehabilitation]. St.Peterburg: Lan. 2000:368. (In Russian).
8. Vrublevsky AH, Anokhina IP, Nuzhniy VP. [Somatic consequences of the use of psychoactive substances]. Toksikologicheskiy vestnik [Poison News].1995:4: 2-5. (In Russian).
9. Masevich TsG, Yermolayeva LG. [Clinical, biochemical and morphological features of chronic hepatitis of different etiology]. Terapevticheskiy arkhiv [Therapeutic Archives]. 2002: 2: 35-37. (In Russian).
10. Anon C, del Olmo J, Llovet F. The hepatitis C virus among the prison population of Valencia. Rev. Esp. Enferm. Dig. 1995: 87(7): 505-508.
11. Charles M, Masihi EJ, Siddiqui HY [et al.] Culture, drug abuse and some reflections on the family. Bull. Narc. 1994: 46(1): 67-86.
12. Sorokina VV [Forensic medical assessment of the causes of death in patients with chronic drug addiction]. Aktualniye voprosi sudebnoy mediciny i ekspertnoy praktiki. Kemerovo [Topical issues of forensic medicine and forensic practice. Kemerovo]. 2003: 1: 247-252. (In Russian).
13. Galyutin SG, Golevtsova ZSh, Vorozhtsov MG. [Nephropathy in people who use opiates]. Nefrologiya [Nephrology]. 2004: 2: 105-106. (In Russian).
14. Rybakova MG, Kapitulskaya TB. [Comparative characteristics of renal disease in infective endocarditis in drug addicts and people who do not use intravenous drugs]. Publisher "Chelyabinsk State Medical Academy." Chelyabinsk. 2008: 125-126. (In Russian).
15. Patent №76565 Ukraine. Sposіb modelyuvannya hronіchnogo opіoїdnogo vplivu / Paltov YeV, Fіk VB, Vіlkhova IV, Onisko RM, Fіtkalo OS, Kryvko YuYa; Lvіvsky natsіonalny medichny unіversitet іmenі Danila Galitsky. - Publ. 10.01.2013, Byul.№1. (In Ukrainian)
16. Korzhevskiy DE, Gilarov AV [Fundamentals of histological techniques] St.Peterburg: Special Lit. 2010: 95. (In Russian).
17. Merkulov GA. [Course of pathological histological technology]. L., 1969: 406. (In Russian).
18. Romeys B. [Microscopic technique]. M.: Medicine, 1953: 71-72. (In Russian).

 

MORPHOLOGICAL FEATURES OF THE WHITE PULP OF THE SPLEEN OF NEWBORN RATS AFTER INJECTIONS OF XENOGENIC CEREBROSPINAL FLUID

Authors: Pikalyuk V.S., Makalish T.P.

Pages: 32-37

Abstract


The spleen is the largest organ of the peripheral immune system in the human body that makes the significant contribution to the immune response, the quantitative and qualitative composition of the immune cells of blood, lymph and other lymphoid organs [3-5]. The influence of various chemical and biological substances on spleen was investigated [2]. Of particular interest among them is xenogenic cerebrospinal fluid (XCSF). The influence of XCSF on the morpho-functional features of ovaries, adrenal glands, bone marrow, mesenteric lymph nodes [1] were revealed, but the structural changes of the spleen after injections of XCSF was not studied. In the early postnatal period there is a rapid development of the lymphoid organs, including spleen, and therefore the response to various factors is expressed. Therefore, the aim of our work was to investigate the histomorphological features of neonatal rat spleen after three and ten times injection of xenogenic cerebrospinal fluid.

The experiment was conducted on Wistar rats of both sexes weighing 10 to 45 g, depending on the time of sampling of the material. All exposures were carried out in accordance with "The international guidelines for biomedical research using laboratory animals." All animals were divided into 2 groups: control and experimental. Each group had two subgroups of six animals, the first of which was administered parenterally saline or XCSF three times, the second one 10 times exposure, every third day, in a dose of 2 ml/kg of body weight. For histological examinations thin slices 3-5 mm thick were made, followed by staining with hematoxylin-eosin.

Based on the data the conclusion was made that triple parenteral administration of XCSF for newborn rats promoted more rapid development of the white pulp of the spleen. Its relative area increased by 60%. By the thirtieth day of life the majority of nodules of white pulp of the spleen already had separate zones. There were secondary nodules containing lymphocytes productive centers. Repeated administration of XCSF for newborn rats caused an increase in the relative area of the white pulp by 18%, while the average square of lymph nodules increased by 44.89% compared to the control group.

Key words: xenogenic cerebrospinal fluid, spleen, white pulp, newborn.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Pikaluk VS, Bessalova EYu, Tkach VV J. at all. Liquor kak gumoralnaya sreda organizma [Liquor as humoral environment of the body]. Simferopol: ARIAL, 2010. 192 p.
  2. Makalish TP. Morfofunkcionalnye izmeneniya selezenki pod deystviem faktorov razlichnogo geneza [Morphofunctional changes of the spleen under the influence of factors of various origin].TMBV. 2013;V16(1):265-269.
  3. Kapitonova MYu, Krayushkin AI, Ryabikina AI, Demidovich IL, Sharaevskaya MV, Nesterova AA. Vozrastnaya gistophiziologiya beloy pulpy selezenki v rannem postnstslnom ontogeneze [Age histophysiology of white pulp of the spleen in the early postnatal period]. Success of modern natural science. 2008;1:93-94.
  4. Kodama R. and al. Age difference in morphology and Immunohistology in the Thymus and spleen in Crl:CD (SD) Rats // Journal of Toxiciligycal Pathology. – 2012. – No 25. – P. 55-61. Access mode: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319772/
  5. Mark F. Cesta. Normal Structure, Function, and Histology of the Spleen // Toxicol Pathol. - 2006. - vol. 34 no. 5. – P. 455-465. Access mode: http://tpx.sagepub.com/content/34/5/455.long.

 

THE INFLUENCE OF INFLAMMATORY INFILTRATION ON HSP90α RECEPTOR EXPRESSION IN BREAST CANCER TISSUES

Authors: Romaniuk A., Lуndіn M., Karpenko L., Budko A., Lyndina Yu., Logvinova O.

Pages: 38-43

Abstract


The passing of breast cancer (BC) is dependent on many factors. Presence of inflammatory infiltration in the stroma and its qualitative composition play one of the key roles. Information about its influence is contradictory. On the one hand the reduction of leukocyte infiltration increases the incidence of damage lymph nodes; on the other hand immune microenvironment of tumor determines the proliferative activity, migration and metastasis of cells. Heat shock proteins or chaperones are a family of highly conserved intracellular proteins. They are constantly synthesized in normal conditions, but under the stress the synthesis significantly is increased. The influence of inflammation and oxidase stress leads to the synthesis of HSP. Hsp90 is responsible for the conformational maturation and repair of more than 300 intracellular proteins that play an important role in the growth, differentiation and maturation of cells. It is known the influence of chaperone 90 on the stability steroid receptors.

Objective of the investigation was the study of Hsp90 synthesis in the presence of inflammatory infiltration in the intercellular neoplastic space and the possibility of its influence on the malignant process.

We selected 43 cases of infiltrative ductal carcinoma of different degree of malignancy by Scarff-Bloom-Richardson. The material was divided into two groups. The first group included 24 cases of breast cancer with the presence of leukocyte infiltration in tumor stromal component, the second - 19 cases without inflammatory infiltration in the stroma. Immunohistochemical reaction took place in 2 stages: I – incubated with primary rabbit antibody at a dilution of 1:200; II - incubation with secondary antibodies (UltraVision ONE HRP Polymer). Mathematical calculations were done using Microsoft Excel 2010 with AtteStat 12.0.5 option.

The presence of inflammatory infiltration in the stromal component of the tumor tissue does not depend on the degree of malignancy of tumor (p>0.05). It was established a correlation between the level of expression chaperones in the epitheliocytes and infiltration of stromal breast cancer tissue (p<0.05). Immune microenvironment stimulates the synthesis in epithelial cells Hsp90α, which may increase their protective properties against the action pharmaceutical preparations and the influence of the macroorganism.

Key words: chaperones, breast cancer, inflammatory infiltration.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Perelmuter VM , Odintsov YuN. [Features inflammatory infiltration in the stroma of invasive ductal breast cancer in the development of recurrence]. Sibirskiy onkologicheskiy zhurnal. 2010;5(41):11-16.
  2. Domschke C, Schuetz F, Ge Y. Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis. Cancer Res. 2009;69(21):8420–8428.
  3. Keibel A, Singh V, Sharma MC. Inflammation, microenvironment, and the immune system in cancer progression. Curr. Pharm. Des. 2009;15(17):1949–1955.
  4. Kampinga HH, Hageman J, Vos MJ. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14(1):105–11.
  5. Grbovic OM, Basso AD, Sawai A. V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors. Proc Natl Acad Sci USA. 2006;103(1):57–62.
  6. Grad I, Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol Cell Endocrin. 2007;275(1–2):2–12.
  7. Picard D. Chaperoning steroid hormone action. Trends Endocrin Metab. 2006;17(6):229–35.
  8. Zagouri F, Bournakis E, Koutsoukos K. Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer. Pharmaceuticals. 2012;5:1008-1020.
  9. Berezowska S, NovotnyA, Bauer K, Feuchtinger A, Slotta-Huspenina J, Becker K, LangerR, Walch A. Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas. PLoS One. 2013;8(7):37-45.
  10. Kregel K.C. Ileal shock proteins: modifying factors in physiological stress responses and acquired Ihemiotolerance / K.C. Kregel // J. Appl. Physiol. - 2002. - Vol.92(5). - P.2177-2186.
  11. SchmittEGehrmannMBrunetMIntracellularandextracellularfunctions heat shock proteins: repercussionsincancertherapyJ.leukoc.Biol. 2007;81(1):15-27.
  12. Shevtsov MA, Hachatryan VA, Margulis BA. [The use of heat shock proteins in clinical oncologists]. Sovremennaya onkologiya. 2012;1:63-68.

 

THE EFFECT OF LAPROXIDE L-303 ON SOME HORMONAL EXCHANE INDICES IN PROLONGED TOXIFICATION OF WHITE RATS

Authors: Rezunenko U., Kucheriavchenko M., Zhukov V., Nikolaeva O.

Pages: 44-50

Abstract


Introduction. Laproxides are classified as simple poly-ethers and are widely used in various fields of national economy as ingredients for manufacturing epoxide resin, varnishes, enamels, plastics, glues, photo-reagents, emulsifiers et cetera. Literature data show that in spite of slight toxicity, poly-ethers are capable of exerting negative impact on the body. This conditions critical need in assessment of their potential safety prognosis for homoithermic animals and humans basing on the evaluation of mechanisms resulting in the development of structural metabolic disorders and determination of integrative systems state necessary for the control of homeostatic function of the body, in which nervous, endocrine and immune systems play a key role.

The objective of the study was to investigate some hormonal exchange indices in subtoxic prolonged exposure of the body to epoxide-containing simple poly-ether L-303 and assessment of potential safety prognosis for homoithermic animals.

Materials and Methods. The trial was performed on mature white Wistar rats of both sexes weighing 180 - 200 g, which for 45 days were perorally administered Laproxide L-303 in doses of 1/100 and 1/1000 DL50. The substance was inserted as water solution with the employment of metallic tube in the morning on an empty stomach. The state of hormonal exchange in control and experiment group was assessed following the completion of acute trial. Radioimmunoassay technique with corresponding reagent sets was employed to evaluate the amount of progesterone, thyroxine, triiodothyronine, insulin, glucagon, prolactin, adrenocorticotropic hormone, luteinizing and follicle-stimulating hormone, estradiole, testosterone, thyrotrophic, somatotropic hormone, calcitonin and parathyrin. The study also involved evaluation of group E prostaglandins – PGE1, PGE2, PGE and group F prostaglandins – PGF2α, 6-keto- PGF1α and leukotriene В4 and С4 contents. Statistical processing of the study outcomes was carried out with the employment of Student-Fischer test.

Discussion. Evaluation of the obtained results is indicative of the fact that Laproxide L-303 in 1/100 DL50 triggers profound impairment of structural metabolic processes in endocrine system on all the levels of its structural functional organization: hypothalamus – hypophysis – adrenal and other glands of internal secretion, which can manifest in dysfunction of all kinds of metabolic exchange and energy. The dose of 1/100 DL50 results in significant stress of protection-adaptation mechanisms, which function is to maintain homeostatic function of the body. In this dose Laproxide L-303 stimulates both catabolic and anabolic processes with predominance of catabolism. Evaluation of hormone dynamics, as well as histohormones contents pro vides evidence of polytropic character of Laproxide L-303 action, which is closely related to the development of membrane pathology. Investigations show that biological action of Laproxide L-303 is characterized by numerous structural metabolic disorders, as well as possibility to condition remote consequences, such as acceleration of body aging, immune deficiency, inhibition of generative function, atherogenesis, mutagenesis and so on.

Keywords: xenobiotics, laproxid, hormones contents, histohormones.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

1. Tsyganenko A.Ya. Scientific bases of the substantiation of potential danger prognosis of detergents in connection with regulation in water of reservoirs / A.Ya. Tsyganenko, V.I. Zhukov, N.G. Sherban [etc.]. – Belgorod, 2001. – 442p. 
2. Zhukov V.I. Environmentally-hygienical description of superficially-active substances as contaminants of reservoirs / V.I. Zhukov, V.V. Myasoedov, S.A. Stetsenko [etc.].- Kharkov: «Tornado», 2000. – 180p.
3. Zhukov V.I. Simple and macrocyclic ethers: scientific bases of water objects protection / V.I. Zhukov, L.D. Popova, O.V. Zaytseva [etc.].- Kharkov: «Tornado», 2000. – 438p.
4. Tsyganenko A.Ya. Environmentally-hygienical description of detergents on the basis of alkylphenols, isononylphenols and secondary spirit fractions C10-20 as contaminants of reservoirs / A.Ya. Tsyganenko, L.G. Shapoval, V.N. Zovskiy [etc.].- Belgorod, 2001. – 177p.
5. Sherban N.G. Biochemical mechanisms of radiomimetic effects superficially- active substances / N.G. Sherban, V.I. Zhukov, V.V. Myasoedov [etc.]. – Kharkov: «Rarities of Ukraine», 2012. – 118p. 
6. Robu A.I. Stress and hypothalamic hormones /A.I. Robu. - Kishinev: «Shtiintsa», 1989. – 220 p.
7. Rozen V.B. Receptors and steroid hormones / V.B. Rozen, A.N. Smirnov. – Moskow .- MSU, 1981. – 310p.
8. Sarkisova D.S. Structural bases of adaptation and compensation of the disturbed functions / D.S. Sarkisova. - Moscow: Medicine, 1987. – 343p.
9. Zhukov V.I. Detergents – modulator of radiomimetic effects / V.I. Zhukov, V.V. Myasoedov, Yu.A. Kozin [etc.]. – Belgorod, 2000. – 374p.
10. Kucherenko N.E. Molecular mechanisms of the hormonal regulation of metabolism / N.E. Kucherenko, Ya.L. Germanyuk, A.N. Vasilev. – Kiev: Higher school, 1986. – 248p.
11. Zhukov V.I. Fluorides: biological role and mechanism of action / V.I. Zhukov, O.V. Zaytseva, V.I. Piven – Belgorod, 2006. – 220p.

 

DETERMINATION NONCULTURABLE STATE OF ENTEROBACTERIA BASED ON ELECTROCHEMICAL ACTIVITY

Authors: Sukhodub L.B., Yudin I.P., Gushilik B.I., Pokhil S.V., Kazmirchuk V.V.

Pages: 51-56

Abstract


Under the influence of the environment pathogenic bacteria may become viable, but nonculturable characterized by the inability of microorganisms to grow in vitro. Indicator assessing the viability of microorganisms enough depends on the characteristics of the method used and the subjective factor, so it becomes more urgent precise quantitative analysis of viable bacteria in the material. The objective of this study was to develop methods for determining the status nonculturable bacteria E. coli, S. sonnei, S. flexneri, S. enteritidis, caused by the action of a biocide - sodium hypochlorite by fluorescence microscopy on membrane filters using fluorochromes rhodamine 123 to identify viable cells and propidium iodide, as an indicator of non-living cells. Research has shown that even after 300 seconds in the biocide action of 1 mg/l of active chlorine still possible to identify viable microorganisms, while under the standard method for seeding onto solid medium the culturability E. coli and S. enteritidis was observed only after 10 second action said biocide concentration, S. sonnei and S. flexneri under these conditions did not show the growth. All tested microorganisms cultured at 20°C, proved to be more resistant to biocide than cultured at 37 °C.

Keywords: enterobacteria, nonculturable state, method of fluorescence microscopy on membrane filters.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Волянський, Ю. Л. Некультурабельний стан аспорогенних бактерiй: теоретичнi аспекти проблеми та її практична значущiсть / Ю.Л.Волянський // Iнфекцiйнi хвороби. - 2004. - №1. - С.5-9.
  2. RollinsD., ColwellRViablebutnonculturablestageCampylobacterjejunianditsroleinsurvivalinthenaturalaquaticenvironment / RollinsD., ColwellR //Appl.
  3. Xu, H. Survival and viability of nonculturable Escherichia coli and Vibrio cholerae in estuarine and marine environment [Text] / H. Xu, N. Roberts, F. Singleton, R. Attwell, D. Grimes, R. Colwell // Microb. Ecol. – 1982. – V. 8. – P. 313-323.
  4. Oliver, J. D. Recent findings on the viable but nonculturable state in pathogenic bacteria [Electronic resource] / J. D. Oliver // FEMS Microbiology Reviews – 2010. – V. 34. – № 4. – P. 415–425.
  5. Morishige, Y. Differential Resuscitative Effect of Pyruvate and its Analogues on VBNC (Viable But Non-Culturable) Salmonella / Y. Morishige, K. Fujimori, F. Amano // Microbes Environ. – 2013. – V. 28(2). – Р. 180–186.
  6. Jayaraman, S. A novel method for the detection of viable human pancreatic beta cells by flow cytometry using fluorophores that selectively detect labile zinc, mitochondrial membrane potential and protein thiols. / S. Jayaraman. // Cytometry Part A – 2008. – V. 73A. – Р. 615–625.
  7. Hewitt, C. J. An industrial application of multiparameter flow cytometry: assessment of cell physiological state and its application to the study of microbial fermentations. / C. J. Hewitt, G. Nebe-von-Caron // Cytometry – 2001. – V. 44. – Р. 179–187. 

 

TRACE ELEMENTS INFLUANCE ON PROSTATE NEURO-ENDOCRINE CELLS MORPHOGENESIS

Authors: Shkrioba A.O.

Pages: 57-62

Abstract


Introduction. There have been a few studies on neuroendocrine system of a prostate in comparison with the studies on NE-cells in other organs until recently. The quantity of published works has increased substantially within the recent years due to the development of immunocytochemical methods, though studies on prostate neuroendocrine system are still at the very beginning .The paper focuses on morphological peculiarities of neuroendocrine cells of the prostate gland under conditions of exposure to heavy metal salts.

Purpose. The purpose of the present work lied in the study of neuroendocrine cells, that secreted chromogranin A, of a prostate of rats under conditions of the influence of heavy metal salts.

Materials and Methods. The experiment was performed in 48 pedigreeless sexually mature (6 months) rats. Morphological peculiarities of neuroendocrine cells, immunoreactive to chromogranin A, of the prostate gland have been studied using immunohistochemical methods.

Discussion. In the result of the held immunohistochemical research it has been demonstrated that under the impact of heavy metal salts the increase of the number of a population of neuroendocrine cells that secreted chromogranin, was observed in the tissue of the prostate gland of experimental rats. The area of expression of chromogranin A increased in the tissue of the prostate in all animals during the whole experiment, and it was significantly higher compared to a control group. This research confirms the protective, adaptive and compensatory nature of the adjustment of neuroendocrine system of a prostate of rats and its role in the pathogenesis of morphofunctional disorders that occur under the influence of heavy metal salts.

Key words: prostate, neuroendocrine system, chromogranin A, heavy metal salts.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Santamaría, Luis, et al. Neuroendocrine Cells and Peptidergic Innervation in Human and Rat Prostrate. Springer, 2007. 79 p.
  2. Pred, K. Zur Frage der Endokrinie der menschlichen Vorsteherdruse. Virchows Arch (Pathol Anat).1944; 312: 392-404.
  3. Pearse, A. G. E. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. Journal of Histochemistry & Cytochemistry. 1969; 17(5): 303-313.
  4. Aumüller, Gerhard, et al. Neurogenic origin of human prostate endocrine cells. Urology. 1999; 53(5): 1041-1048.
  5. Helle, Karen B. The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects. Biological Reviews. 2004; 79(04): 769-794.
  6. Helle, K. B., et al. The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties. Cellular and Molecular Life Sciences. 2007; 64(22): 2863-2886.
  7. Schmid-Schönbein, Daniel TO'Connor, and Sushil K. Mahata. Global metabolic consequences of the chromogranin. J. Biol. Chem. 2014; 289(7): 4455-4469.
  8. D'amico, Maria Angela, et al. Biological function and clinical relevance of chromogranin A and derived peptides. Endocrine connections. 2014; 3(2): 45-54.
  9. Toni, R. The neuroendocrine system: organization and homeostatic role. Journal of endocrinological investigation. 2003; 27(6): 35-47.
  10. Raikhlin N.T., Kvetnoy I.M. The APUD system (diffuse endocrine system) in normal and pathological states. Physiol. Gen. Biol. Rev. 1994; 8(4): 1-44.

 

TREATMENT ANALYSIS OF CHILDREN WITH CONGENITAL MULTIPLE DEVELOPMENT DEFECTS

Authors: Avramenko I.

Pages: 63-69

Abstract


Congenital development defects (CDD) are a difficult medical and much more social problem. They are observed in 3-5% of newborns and are a cause of 20% infant deaths. The opportunity of modern ex-amination methods as well as improvement in operative technique and perioperative care and rehabilitation gave a chance to improve considerably the results of CDD patient treatment. However, CDD is further one of main lethality causes of newborns, infants and children of early years as well as one of key causes of children’s disability. It is not always able to make a full correction of congenital multiple development defects. Alternate surgical treatment depends mainly on defect constituents and hospital potentials. Therefore, treatment algorithm of different combined development defects is not finally developed and under discussion.

The aim of our research is to analyse the results of treatment and priority of helping children with congenital multiple development defects, among of which there is a heart defect.

It is done a retrospective analysis of medical documents on children with congenital multiple development defects and congenital heart defects at the age of less than one year. All results were statistically worked out by means of an original computer program Microsoft Ex-cel.

Most of all congenital heart defects are combined with anomalies of the urinary system and the gastrointestinal tract, rarely they are combined with development defects of the nervous system, a skeleton and respiratory organs. The anomaly of a skeleton and the urinary sys-tem influences rarely on a patient status, but does not need emergency surgical treatment. Critical congenital heart defects at CDD require surgical treatment first of all. Noncritical congenital heart defects influence on the course of postsurgical period and are to be taken into consideration while children with CCD undergo the treatment. The anomaly of the gastrointestinal tract is crucial in the destabilization of a patient clinical state and needs surgical treatment in the very period of newbornness. Considerably higher mortality after surgical treatment is connected with doing palliative operations, but not with completed correction of development defects.

Carrying out a research of multiple organ congenital anomalies makes it able to understand better aetiology and pathogenesis of their occurrence; moreover the profound analysis of the treatment provided makes it able to set priorities of helping such patients.

Key words: congenital multiple development defects, congenital heart defects, children.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Maroszyńska I. Postępowanie po urodzeniu z noworodkiem z zespołami wielu wad wrodzonych. Standardy medyczne/Problemy chirurgii dziecięcej. 2011;2:139.
  2. Ferencz C, Boughman JA, Neill CA, Brenner JI, Perry LW. Congenital cardiovascular malformations: questions on inheritance: Baltimore-Washington Infant Study Group. J Am Coll Cardiol. 1989;14:756-763.
  3. Hanna EJ, Nevin NC, Nelson J. Genetic study of congenital heart defects in Northern Ireland (1974 – 1978). J Med Genet. 1994;31:858-863.
  4. Kalashnikova RV, Rudenko NN, Romaniuk AN, Galagan VA, Emets IN. Structure of congenital development abnormalities in operated for congenital heart diseases children. Modern Pediatrics. 2013;7(55):140-144.
  5. Pradat P, Francannet С, Harris JA, Robert E. The epidemiology of cardiovaskular defects, I: a study based on data from three large registries of congenital malformation. Pediatr Cаrdiol. 2003;24:195-221.
  6. Miller A, Riehle-Colarusso T, Alverson J, Frias JL, Correa A. Congenital Heart Defects and Major Structural Noncardiac Anomalies, Atlanta, Georgia, 1968 to 2005. J Pediatr. 2011;159:70-78.
  7. Okada PJ, Nicks B. Neonatal surgical emergencies. Clin Ped Emerg Med. 2002;3:3-13.
  8. Wojtalik M, Mrówczyński W, Henschke J, Wronecki K, Siwińska A, Piaszczyński M et al.Congenital heart defect with associated malformations in children. J Pediatr Surg. 2005;40:1675-1680.
  9. Beasley SW, Oldham KT, Colombani PM, Foglia RP (eds). Esophageal atresia and tracheoesophageal fistula. Surgery of Infants and Children: Scientific Principles and Practice. Philadelphia, PA, Lippincott-Raven. 1997;1021 – 1034.
  10. Kimura K, Loening-Baucke V. Bilious vomiting in the newborn: Rapid diagnosis of intestinal obstruction. Am Fam Phys. 2000;61:2791 – 2798.
  11. Meurs KV, Short BL, Meurs KV. Congenital diaphragmatic hernia: The neonatologist’s perspective. Pediatr Rev. 1999;20:E79-E87.
  12. Harrison MR, de Lorimier AA. Congenital diaphragmatic hernia. Surg Clin North Am. 1981;6:1023 - 1035.

 

SOME FEATURES OF THE IMMUNE SYSTEM IN CHILDREN WITH LOCAL FORMS OF TUBERCULOSIS

Authors: Bielogortceva O.I., Dotcenko Ya.I., Rekalova O.M., Pobedionna G.P., Sivachenko O.E.

Pages: 70-76

Abstract


Introduction. The epidemiological situation of tuberculosis (TB) in Ukraine remains tense, including among children and adolescents. The immune system can identify children likely to develop TB, characteristics of the disease and its prognosis.

The aim was to study the features of cell-mediated immunity of children with local forms of TB.

Materials and methods. Were examined 44 patients aged 5 to 16 years who have had a positive Mantoux test with 2TO with newly diagnosed TB (NDTB). Children were divided into two age groups - 5-9 and 10-16 years. The control group comprised 44 healthy BCG vaccinated children aged 5 to 16 years, not M. tuberculosis infection who have been treated in NIFP NAMS for 2012-2014 about further diagnosis. In the age group 5-9 years were 20 children in the respective control group - 26 healthy, vaccinated with BCG, children of the appropriate age and gender of children with local forms VDTB aged 10-16 years - 24 children in the control group - 18 children same age and sex. In children studied content CD3 + -, CD4 + -, CD8 + -, CD4 + -, CD16 + -, CD19 + lymphocytes with sets of monoclonal antibodies BD Simultest CD3 / CD16 + CD56, CD3 / CD19, CD4 / CD8 (USA).
Results. Children in age group 5-9 years with a local TB showed a decrease CD4/CD8 ratio with a decrease of absolute and relative content of B-cells. Children 10-16 years old was diagnosed secondary immunodeficiency due to inhibition of T- and B-cell immunity, decreased absolute number of T-lymphocytes, absolute and relative content of CD4 +-, CD16+-, CD19+-lymphocytes with decreasing absolute number of CD8+-cells with not changed CD4/CD8 ratio. These changes can help determine the direction and volume of immunocorrection.

Key words: children, tuberculosis, indicators of cellular immunity.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Prichiny disregulyatsii immunnogo otveta pri tuberclyoze legkikh: vliyaniye M. tuberculosis na techenije immunnogo otveta [Теxt] / E.I. Esimova, O.I. Urazova, V.V. Novitskij [et al.] // Bulleten’ Sib. mediciny – 2012. – № 3. – P. 79-86.
  2. Contribution of CD14-159C/T polymorphism to tuberculosis susceptibility: a meta-analysis [Text] / J. Zhao, G. Lin, W-H. Zhang, [et al.] // The International Journal of Tuberculosis and Lung Disease. – 2013. – Vol. 17, № 11. – P. 1472-1478.
  3. Аssotsiirovanije umen’shenija kolichestva Т-kletok 1-go tipa v perifericheskoi krovi bolnikh tuberculozom legkikh so snizheniem ekspresii kostimulyatornikh molekul CD-80 na моnоtsitakh [Теxt] / О.V. Теmchura, V.V. Senukov, N.V. Pronkina [et al.] // Problemy tuberculeza i boleznei legkikh. – 2007. – № 2. – P. 25-28.
  4. Estestvenno-killernyi immunodeficit i gerpes-virusnaja infectsija pri tuberculoze [Теxt] / M.А. Каralyan, S.М. Stеpаnyan, А.К. Ulumyan, E.Т. Каrаpеtyan // Problemy tuberculeza i boleznei legkikh. – 2007. – № 3. – P. 25-27. 
  5. Bilogortseva О.І. Еpidemioilichna sytuatsija schodo tuberculozu u ditei ta po-kaznyki protytubercul’oznoi roboty sered dytizchogo naselennia v Ukraine u 2012 rotsi [Теxt] / О.І. Bilogortseva // Маterialy V z’izdu phthyziatriv i pulmonologiv. – 2013. – P. 24–29.
  6. Аverbakh М.М. Tuberculioznaja granul’oma. Sovremennii vzgliad na immunogenez i kletochnii sostav [Теxt] / М.М. Аverbakh // Tubercul’oz i bolezni legkikh. – 2010. – № 6. – P. 3-9.
  7. Ginda S.S. Kharakteristika immunnogo onveta u deteij s razlichnymi oslozhnenijami posle vakcinacii i re vakcinacii vakcinoi БЦЖ [Текст] / S.S. Ginda, К.М. Yavorskii, S.S. Kulchitskaja // Tubercul’oz i bolezni legkikh. – 2013. – № 6. – P. 24-25.
  8. Polioxidonii v komplexnom preventivnom lechenii tuberculioza u detei i podrostkov [Теxt] / A.S. Pozdniakova, N.S. Shpakovskaja, E.I. Каtebnikovа [et al.] // Tubercul’oz i bolezni legkikh. – 2010. – № 1. – С. 45-49.

 

ASSESSMENT OF THE STATUS OF THE FETUS IN PREGNANT WOMEN WITH CARDIAC ARRHYTHMIAS

Authors: Boyko V.I., Sukharev A.B., Nikitina I.N.

Pages: 77-82

Abstract


The aim of this study was to investigate the hemodynamic features in the "mother-placenta-fetus", the functional state of the fetus in pregnant women with ekstrosistoly and paroxysmal tachycardia.

In order to clarify the diagnosis to all pregnant women during their stay in the maternity hospital performed tests: ECG, echocardiography, consultation of a cardiologist.

In the study used the following methods: cardiotocography fetal echographic study of the fetus, placenta, doplerometrii fetoplacental complex.

The survey showed that in pregnant women with heart rhythm disorders as ekstrosistoly hemodynamics in the "mother-placenta-fetus", fetal biophysical profile parameters were not significantly different from healthy pregnant.U women with paroxysmal tachycardia have been certain circulatory disorders in the uterine arteries, umbilical artery ., which do not significantly affect the performance of fetal biophysical profile.

Results of the study confirmed: the state of the fetus in pregnant women with these cardiac arrhythmias is not distress.

Based on the findings it can be concluded that the alleged tactics of birth in pregnant women with ekstrosistoly and paroxysmal tachycardia is defined obstetric situation.

Recommendations made as a result of the study were implemented in obstetric clinic.

Requires further study of the fetus in the latent and active phase of labor.

Keywords: pregnant, cardiac arrhythmia, fetal biophysical profile, cardiotocography.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

1. AbdulaevaF.M, Shmidt E.Yu ,.Yabluchanskiy N.I.Zheludochkovaya ekstrasistolicheskaya aritmIya u beremennyih. UkraYinskiy kardIologIchniy zhurnal #1,2014.s102-110.
2. Voskresenskiy S. L. Otsenka sostoyaniya ploda. Kardiotokografiya. Dopplerometriya. Biofizicheskiy profil: Ucheb. Posobie. – MN.: Knizhnyiy dom, 2004. – 304 s.
3. Kleschenogov S.A. Prognozirovanie oslozhneniy beremennosti na osnove izucheniya variabelnosti ritma serdtsa. Byulleten SO RAMN,#3(121),2006.s.52-59.
4. Nikitina Yu. M., Truhanova A. I. Ultrazvukovaya doplerovskaya diagnostika v klinike – Ivanovo: Izdatelstvo MIK, 2004. – 496 s.
5. Nakaz vId 27.12.2006 # 900 Pro zatverdzhennya klInIchnogo protokolu z akusherskoYi dopomogi "Distres ploda pri vagItnostI”.
6. Medved V. I. Vvedenie v kliniku ekstragenitalnoy patologii beremennyih. –K.Gidromaks, 2007. – 168 s.
7. Strizhakov A. N., Davyidov A. I., Belotserkovtseva L. D. Fiziologiya i patologii ploda. - M.:Meditsina, 2004. – 356 s.
8. Stryuk R.I.Zabolevaniya serdechno-sosudistoy sistemyi i beremennost M. GEOTAR-Media,2010 s.300.
9. Filipov O. S. Platsentarnaya nedostatochnost. – M.: MEDpress-inform, 2009. – 160 s.
10. Shehman M. M. Rukovodstvo po ekstrogenitalnoy patologii u beremennyih – M.:Triada – H, 2005. – 816 s.

 

THE PECULIARITIES OF CARDIORENAL RELATIONS IN PATIENTS WITH MIXED PATHOLOGY - CHRONIC HEART INSUFFICIENCY ON THE BACKGROUND OF ISCHEMIC HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Authors: Vynnychenko L.B., Demikhova N.V., Vynnychenko K.A.

Pages: 83-92

Abstract


The aim of the study was to examine the peculiarities of cardiorenal relations in patients with mixed pathology - chronic heart insufficiency (CHI) on the background of ischemic heart disease (IHD) in combination with chronic obstructive pulmonary disease (COPD). A total of 134 patients aged from 45 to 78 years, comparable by age and sex, with CHI II of functional class (FC) III of ischemic origin. The main group consisted of patients with CHI II, FC III with concomitant COPD II, stage III (n = 74). The control group (group II) represented patients with CHI II, FC III without disrupting of respiratory function (RF) (n = 60). The study of morphofunctional state of the myocardium showed that for the same functional class of CHI in patients with concomitant COPD, compared with patients with CHI without COPD we observe a significant increase in the size of the right atrium (RA), right ventricular (RV), the average diameter of the pulmonary artery (ADPA); significantly more often we observe arterial hypertension, left ventricular hypertrophy (LVH), prognostically unfavourable types of LV remodeling (concentric and eccentric), the number of people with "delayed" type of diastolic dysfunction of the left ventricle (DD LV) is decreased due to increasing the proportion of patients with an intermediate "pseudonormal" violation of DD LS.

In patients with mixed pathology - CHI on the background of IHD with COPD compared with those without CORD more frequently we observed clinically significant: increase in serum creatinine (35,1% vs 10%, respectively, p <0.05), reduced glomerular filtration rate (GFR) (<60 ml / min / 1,73m2) (47,3% vs 25,0%, respectively, p <0.05), exhausted funktsionalnіy renal reserve (FRR) (47,3% vs 15%, respectively, p <0.05) microalbuminuria (MAU) (89,2% vs 61,7%, respectively, p <0.05). It is discovered that increasing the MAU is associated with dilation of the right parts of the heart, reduction of tolerance to physical exercise and an increase in the severity of CHF. The increase of Urine Specific Gravity (USG) is due to decrease in RV dilatation. It is proved that the maximum percentage of patients with MAU and exhausted FRR, clinically significant reductions in GFR, increased КК and decrease of the relative density of urine was observed among patients with stage III COPD, as well as in patients with FC III CHI. It is determined that eccentric hypertrophy and concentric hypertrophy of the LV are accompanied by a more symptomatic deterioration in glomerular and tubular nephron function.

Keywords: chronic heart insufficiency, coronary heart disease, chronic obstructive pulmonary disease, cardiorenal syndrome.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Karpov RS, Dudko VA, Klyashev SM [Heart - lung]. Tomsk, 2004. – 605p. (In Russian)
  2. Chuchalin AG [Guide in respiratorymedicine]. - М, 2007. – 814p.(In Russian)
  3. Avdeev SN, Baymakanova GE [Strategy of cardiac patients suffering from Cardiopulmonary relations]. Serdtse [Heart]. 2007: 6: 308-309. (In Russian)
  4. Huiart L, Emst P, Suissa S Cardiovascular morbidity and mortality in COPD. 2005: 128 (4)2640-
  5. Gjerge B, Bakke P, Ueland T, Hardie JA, Eagan TM The prevalence of undiagnosed renal failure in a cohort of COPD patients in Western Norway. Respir. 2012: 106:361-366.
  6. Ronco C, House AA, Haapio M [Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong]. Intensive Care Med. 2009: 34: 957-962.
  7. Maclay JD, McAllister DA, Mills NL, Paterson FP, Ludlam CA, Drost BM, Newby DE, Macnee W Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009: 180513-520.
  8. Mareyev VY, Ageev FT, Arutyunov GP et al. [National guidelines RNCS and HFS for the diagnosis and treatment of chronic heart failure]. Serdechnaya Nedostatochnost [Heart failure]. 2007: 8 (1)34-41.(In Russian)
  9. Gozhenko AI, Haminich AV, Lebedev TL, Gozhenko OA [Method of determining functional renal reserve]. PatUkraine number 42860IPC (2009) A61 B5/20; № u200901459Applications02/23/09; . - 4 p. (In Ukrainian)
  10. "On approval and introduction of medical and technological documents in chronic Order of Education and Science Ministry of Ukraine (In Ukrainian)
  11. "Global Initiative for Chronic Obstructive Lung Disease". National Institutes of Health, 2013. - 100р.

 

PREHOSPITAL TRAITS OF PATIENTS WITH GASTROINTESTINAL EROSION AND ULCER BLEEDINGS

Authors: Duzhiy I.D., Aleksandrenko A.V., Bratushka V.O., Bilous G.V., Kharchenko S.V.

Pages: 93-98

Abstract


Introduction. The prehospital phase is a responsible component of conservative and surgical treatment for patients with any pathological process, particularly a gastroduodenal bleeding of ulcer or erosion origin, because a bleeding is often premortal condition where clinical success depends in the main from care giving time. The aim is to study motivational causes of calls in emergency rota for patients with erosion and bleedings, diagnostic difficulties and traits of patient transportation during the prehospital phase.

Methods and materials. Thirty one patients with ulcer and erosion bleedings of the stomach and the duodenum, and patient documentation were analyzed.

Results. During the prehospital phase the major cause of calls in emergency rota was specific as for bleeding: the melaena in 15 patients(48,4%), the hematomesis in 2 (6,4%); the nonspecific causes gave the minority (45,2%). The number of the said causes during hospitalization rose remarkably: the melaena in 1.7-fold (80,6%), the hematomesis in 5-fold (32,3%). Meanwhile the principal symptom on hospitalization was nonspecific as a general weakness.

Conclusions. The principal cause of calls in emergency rota remains reliable signs of the bleeding (melaena, hematomesis). On hospitalization the number of such manifestation of the bleeding rises 1.7–5-fold. In a case of gastrointestinal bleeding suspicion it is recommended a diagnostic algorithm and a transportation in the supine with infusion support from the start. This may prevent or minimize bleeding prolongation.

Key words: ulcer bleeding, diagnostics, prehospital treatment.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

1. Kaviani MJPirastehfar MAzari ASaberifiroozi MEtiology and outcome of patients with upper gastrointestinal bleeding: a study from South of Iran. Saudi. J. Gastroenterol.2010Oct-Dec;16(4):253-9.

2. Lee LIqbal SNajmeh SFata PRazek TKhwaja KMesenteric angiography for acute gastrointestinal bleed: predictors of active extravasation and outcomesCan. J. Surg. 2012 Oct 1;55(5):005611-411.

3. FominPD [editorinchief]. Udoskonaleni alghorytmy diaghnostyky ta likuvannja ghostrojishlunkovo-kysh krovojikrovotechi (metodychni rekomendaciji)[Advanced algorithms of diagnostics and treatment for acute gastrointestinal bleeding (methodical recommendations)].The Ministry of Healthcare of UkraineKyiv, 2012. 108 p. [InUkrainian]

4. FominPDZhaporozhanS.Y., DeikaloI.M., MalevychYu.AOsoblyvosti likuvaljnoji taktyky khvorykh na vyrazkovu ghastroduodenaljnu krovotechu u peredshpytaljnomu etapi. [Particularitiesof the treatment tactics for patients with gastroduodenal ulcer bleeding on prehospital stage].  Acta Medica Leopoliensia. 2011(1); XVІІ: 45-48. [InUkrainian]

5. Nikonov VV, Belebezev GG [editors in chief]. Ekstrennaja medciinskaja pomoshhj na doghospytaljnom эtape. Praktycheskoe rukovodstvo.[Emergency medical aid on the prehospital stage. A practical manual]. Luhansk, 3rd edition, revised and supplemented. 2006, 224 p. [In Russian]

6. Nakaz Ministerstva okhorony zdorov'ja 02.04.2010 # 297. "Pro zatverdzhennja standartiv ta klinichnykh protokoliv nadannja medychnoji dopomoghy zi specialjnosti «Khirurghija»". [Order by the Ministry of Healthcare of Ukraine № 297 from 02.04.2010"About establishment of standards and clinical protocols for medical treatment in the speciality«Surgery»"]. [InUkrainian]

7. Nakaz Ministerstva okhorony zdorov'ja 15.01.2014  # 34. Unifikovanyj klinichnyj protokol ekstrenoji medychnoji dopomoghy «Ghipovolemichnyj shok». [Order by the Ministry of Healthcare of Ukraine № 34 from15.01.2014. The unified clinical protocol for emergency medical aid «Hypovolemic shock»]. [InUkrainian]

8. Bereznytskyi YS [editor in chief].Standarty orghanizaciji ta profesijno orijentovani protokoly nadannja nevidkladnoji dopomoghy khvorym z khirurghichnoju patologhijeju orghaniv zhyvota ta ghrudnoji klitky. [Organisation standards of professionally oriented protocols for emergency aid to patients with surgical diseases of the abdomen and the thorax].Kyiv, 2008, 310 p. [InUkrainian].

 

FEATURES OF BLOOD ELECTROLYTE BALANCE IN NEWBORNS WITH KIDNEY DAMAGE AND ASPHYXIA

Authors: Loboda A.N., Markevich V.E.

Pages: 99-109

Abstract


The study of the concentration of main electrolytes in serum of blood and erythrocytes in neonates with impaired renal function due to asphyxia is important, because it allows to determine violations of their content and balance, tactics of infusion and diuretic therapy. The purpose of the work is explore the features of the content and balance of electrolytes (sodium, potassium, calcium, magnesium) in serum and red blood cells of newborns with disturbance kidney function due to asphyxia.

The study involved 200 term infants with signs of disturbance kidney function: 100 children who have suffered severe asphyxia, 100 children – with moderate asphyxia. Comparison group consisted of 20 infants without asphyxia at birth. The content of electrolytes determined by emission photometry, also expected ratios in pairs Na/K and Ca/Mg and transmembrane ratio of trace elements.

The critical period of formation electrolyte imbalances in neonates with impaired renal function due to moderate asphyxia is the early neonatal period, in case of severe asphyxia – all neonatal period. The feature of ischemic renal impairment in newborns is the development of serum hypernatremia and hyperkalemia, hypocalcemia and hypomagnesemia, decrease the ratio of Na/K and increase Ca/Mg. Red blood cell pool of macroelements in case of neonatorum ischemic nephropathy is characterized by the growth of sodium level and deficiency of potassium, calcium and magnesium, as well as growth transmineralisation Na/K ratio and decrease Ca/Mg. Growth transmembrane ratios relative to sodium and magnesium reflects their transport into the cell, and reducing ratios relative potassium and calcium indicates the predominance of these electrolyte transport in the extracellular fluid. Changes in serum and intracellular electrolyte content and balance must be considered during infusion therapy in infants with impaired renal function due to asphyxia.

Keywords: kidney, electrolyte, balance, relationship, blood.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Kurinczuk J.J., White-Koning M., Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 2010; 86: 329–38.
  2. Wall S.N., Lee A.C., Carlo W., Goldenberg R., Niermeyer S., Darmstadt G.L., et al. Reducing intrapartum-related neonatal deaths in low- and middle-income countries-what works? Semin Perinatol. 2010; 34: 395–407.
  3. Morales P., Bustamante D., Espina-Marchant P., Neira-Pena T., Gutiérrez-Hernández M.A, Allende-Castro C., et al. Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes? The Epma Journal. 2011; 2(2): 211–230.
  4. Mohan P.V., Pai P.M. Renal insult in asphyxia neonatorum. Indian Pediatrics. 2000; 37: 1102 – 1106.
  5. Skal'nyy A.V. Khimicheskie elementy v fiziologii i ekologii cheloveka. – M.: ONIKS 21 vek: Mir, 2004. – 216 р.
  6. Mikroelementozy cheloveka: etiologiya, klassifikatsiya, organopatologiya / Avtsyn A.P., Zhavoronkov A.A., Rish M.A., Strochkova L.S. – M.: Meditsina, 1991. – 496 р.
  7. Kulikova N.Yu., Chasha T.V., Mozhaeva A.N., Kuz'menko G.N., Sitnikova O.G. Ishemicheskaya nefropatiya u novorozhdennykh, kliniko – laboratornaya kharakteristika, prognozirovanie i rannyaya diagnostika. Zdorov'ye rebenka. 2010; 2(23): 104-107.
  8. Statisticheskie metody v mediko-biologicheskikh issledovaniyakh s ispol'zovaniem Exel / Lapach S.N., Chubenko A.V., Babich P.N. – K.: MORION, 2001. – 408 р.
  9. Klinicheskaya otsenka rezul'tatov laboratornykh issledovaniy / Nazarenko G.I., Kishkun A.A. – M.: Meditsina, 2006. – 544 р.
  10. Basu P., Som S., Das H., Choudhuri N. Electrolyte status in birth asphyxia. Indian J. Pediatr. 2010; 77(3): 259 – 262.
  11. Sweetman D.U., Riordan M., Molloy E.J. Management of renal dysfunction following term perinatal hypoxia-ischaemia. Acta Paediatr. 2013; 102 (3): 233 – 241.
  12. Ng P.C. Effect of stress on the hypothalamic-pituitary-adrenal axis in the fetus and newborn. J. Pediatr. 2011; 158 (2): 41 – 43.
  13. Svobodnoradikal'nye protsessy i vospalenie (patogeneticheskie, klinicheskie i terapevticheskie aspekty) / Sologub T.V., Romantsov M.G., Chesnokova N.P. – M.: Akademiya estestvoznaniya, 2008. – 143 р.
  14. Gromova O.A. Neyrotroficheskaya sistema mozga: neyropeptidy, makro- i mikroelementy, neyrotroficheskie preparaty. Mezhdunarodnyy nevrologicheskiy zhurnal. 2007; 2 (12): 94 – 106.
  15. Sheybak M.P. Defitsit magniya i ego znachenie v patologii detskogo vozrasta. Ros. vestn. perinatologii i pediatrii. 2003; 1: 45 – 47.
  16. Ikari A., Okude C., Sawada H., et al. Activation of a polyvalent cation–sensing receptor decreases magnesium transport via claudin–16. Biochim. Biophys. Acta. 2007; 1778 (1): 283 – 290.

 

MINIMIZATION OF THE EARLY POSTOPERATIVE COMPLICATIONS AFTER ENDOVENOUS LASER COAGULATION WITH DIFFERENT IRRADIATION SOURCES

Authors: Melekhovets Y.V., Leonov V.V., Melekhovets О.К., Marchenko E.E.

Pages: 110-116

Abstract


Introduction. Endovenous laser coagulation (EVLC) of varicose veins was proposed as a minimally invasive alternative to conventional surgery for varicose disease of the lower limbs. Various strategies were proposed for optimal management. But until now, the safety and effectiveness of different endovenous laser ablation regiments for varicose disease has not been fully evaluated.

Purpose. The objective of this study was to compare efficacy and side effects of endovenous laser coagulation (EVLC) in early postoperative period using an 940-nm, 1470-nm и 445-nm diode lasers.

Materials and Methods. 142 patients, diagnosed with varicose disease of the lower limbs with CEAP classification 2 to 6, were enrolled in this study. We compared three groups of the patients: 1 group – 48 patients, who was treated with an endovenous diode 940-nm laser by pulse regime 50:10 emission at 15 – 18 W, 2 group – 53 patients with an 1470-nm diode laser by continuous emission at 7 to 9 W, 3 group – 41 patients with an 445-nm diode laser by continuous emission at 1,5 to 2 W. Intravascular laser ablation was performed with variable retraction speed. Spinal or local, but not tumescent, anesthesia was used.

A duplex ultrasound examination (combination of the traditional ultrasound with color and spectral Doppler) was performed to evaluate degree of reflux in junction of the common femoral vein with the great saphenous vein, make an assessment of the local haemodynamics, vein wall characteristic ets.

Discussion. Patients were scheduled for duplex sonography follow-up at Day 1 and also at 1, 2, 3 and 4 weeks, postoperatively.

Objective examination was performed at 1 day, 1, 2, 3 and 4 weeks after the procedure. Clinical characteristics include: pain sing, sensitivity disturbances and local postablation inflammation sings (infiltration, hyperaemia, oedema, pain along treated vein). Measurement of pain in the patients in early postoperative period was evaluation with Verbal Descriptor Scale (Gaston - Johansson F., Albert М., Fagan E. et al., 1990).

It was found minimum tissues injury in patients, who was treated by intravascular laser ablation lengthwise 1470 nm и 445 nm, compared an endovenous diode 940-nm laser, that provides with favourable effect on postoperative period.

Key words: Varicose Disease, Endovenous Laser Coagulation, Varicose Veins, Laser Ablation, Postoperative Period, Duplex Ultrasound Examination.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Alekperova TV., Kirienko AP, Bogachov VU., Zolotuhin IA Lechebno-diagnosticheskie tehnologii ambulatornoy hirurgii varikozno y bolezni ven nijnih konechnostey [Treatment and diagnostic technology of the outpatient surgery of the varicose disease of the lover limbs]. Abulatornaya hirurgiya. Moskva, 2001. – Vol. 2(2). - pp. 5-9. (In Russian).
  2. Bogachev VU. Nachalnie formi hronicheskoy venoznoy nedostatochnosti nijnih konechnostey (epidemiologiya, patogenez, diagnostika, lechenie i profilaktika) [Early forms of the lover limb chronic veins insufficiency (epidemiology, pathogenesis, diagnostic, treatment and prophilacsis)]. Flebolimfologiya. Moskva, 2004. - Vol. 21. – pp.10 – 13. (In Russian).
  3. Larin SI. Ispol’zovanie razlichnih vidov endovazalnoy lazernoy koagulyacii v lechenii varikoznoy bolezni ven nijnih konechnostey. [Using of the different types of endovasal laser coagulation in varicose disease of the lower limbs]. Flebolimfologiya. VI Konferenciya Associacii flebologov Rossii. Moskva, 2006. – P. 122. (In Russian).
  4. Pokrovskiy AV, Sapelkin SV. Klassifikaciya CEAP i ee znachimost dlya otechestvennoy flebologii [CEAP classification and its significance for national flebology]. Angiologiya i sosudistaya hirurgiya. Moskva, 2006. – Vol.12 (1), pp. 65-74. (In Russian).
  5. okrovskiy AV., Sapelkin SV., Letunovskiy EA. Ispolzovanie metoda ehdovazalnoy lazernoy koagulyacii v lechenii varikoznoy bolezni [Using of the method of endovasal laser coagulation in varicose disease treatment]. Rossiyskiy medicinskiy jurnal. Moskva,2007. Vol.1, pp.41-43. (In Russian).
  6. Gaston-Johansson, F., Albert, M., Fagan, E., & Zimmerman, L. (1990). Similarities in pain descriptions of four different ethnic-culture groups. Journal of Pain and Symptom Management, 5, 94–100
  7. Goldman M.P. Pathophysiology of varicose veins. In book Sclerotherapy. Treatment of varicose and telangiectatic leg veins. 4-th edition /M.P. Goldman, J.J.Bergan, J.-J. Guex// Mosby Elsevier. 2007. - P.49-72
  8. Kaspar S. Standardisation of parameters during endovenous laser therapy of truncal varicose veins experimental ex-vivo study /S. Kaspar, J. Siller, Z. Cervinkova, T. Danex// Eur. J. Vase. Endovasc. Surg. 2007. - Vol.34, №3. - P.224-228.
  9. Kim H.S. Lower enercy endovenous laser ablation of the great saphenous vein with 980nm diode laser in continuous mode /H.S. Kim, I.J. Nwankwo, K. Hong, PSJ. McElgunn// Cardiovasc intervent Radiol. 2006. - №29. - P.64-69.
  10. Mekako A.I. A nonrandomised controlled trial of endovenous laser therapy and surgery in the treatment of varicose veins /А.1. Mekako, J. Hatfield, J. Bryce, D. Lee, P.T. McCollum, I. Chette// Vase Surg. 2006. - Vol.20. - P.451-457.
  11. Myers K.A. Duplex ultrasonografy scanning for chronic venous desease: patterns of venous eilux /K.A. Myers, R.W. Ziegenbein, G.H. Zeng, P.G. Mathews// J.Vasc. Surg. 1995. -P.605-612.

 

EFFECTIVENESS OF BRONCHIAL ASTHMA BASIC THERAPY, DEPENDING ON GENOTYPE OF BCL1 POLYMORPHISM OF GLUCOCORTICOID RECEPTOR GENE

Authors: Orlovkskiy V.F., Kmyta V.V.

Pages: 117-123

Abstract


It is known that reduced responsiveness to asthma treatment in about half of patients is due to genetic peculiarities.

Taking into account proved role of Bcl1 gene polymorphisms of glucocorticoid receptor (GR) in the occurrence of bronchial asthma (BA) and changes in response to glucocorticoids (GCS), the aim of our study was to evaluate effectiveness of bronchial asthma basic therapy, depending on genotype of BCL1 polymorphism of glucocorticoid receptor gene.

Materials and methods. 188 patients with BA have been examined. The control group consisted of 95 apparently healthy adult individuals. Effectiveness of treatment was assessed with the help of ACQ questionnaire and forced expiratory volume in 1 second (FEV1) after 4 and 16 weeks of treatment.  During 4 weeks of treatment all patients received low-dose inhaled glucocorticoids (IGCS)  with prolonged β2-agonists, and the next 12 weeks, patients with partially controlled, uncontrolled - middle doses of IGCS. The determination of allelic polymorphism in the second exon of the GR gene, Bcl1 (C647G) - rs41423247, was performed by polymerase chain reaction (by Fleury I. еt al.) with modifications.  Statistical analysis of the results was performed using SPSS-17 program.

Results. BA control analysis excluding genetic factors have been demonstrated that 8.5% of patients had complete control, 68.6% - partially controlled, and in 22.9% - uncontrolled. Investigation of  BA control depending on the genotype of Bcl1 polymorphism of the GR gene showed the presence of a statistically significant difference in the distribution of allelic variants of the gene by χ2 Pearson criterion (p = 0.001).

C/C genotype was associated with controlled and G/G genotype - with uncontrolled BA. Analysis of BA control depending on the genotype of Bcl1 polymorphism of the GR gene showed that its level increased after 4 weeks of treatment (p <0.001) in patients with C/C, C/G and G/G genotypes and was accompanied with significant increase in FEV1.

On the next stage patients without enough BA control have been selected: 92 partially controlled (group I) and 23 uncontrolled (group II), and dosage of IGCS have been increased. The level of control in the group I depending on the genotype of Bcl1 polymorphism of GR gene after 12 weeks increased in patients with C/G genotype and  was significantly higher compared with patients with G/G genotype. FEV1 before and after basic treatment was lower in patients with G/G genotype compared to C/C and C/G genotypes (p = 0.001).

Analysis of BA control and FEV1 in patients with uncontrolled course depending on the genotype of Bcl1 polymorphism of the

GR gene showed that treatment with medium doses of IGCS has contributed to the control, but in patients with G/G genotype was significantly lower compared with the same in patients with C/C genotype . FEV1 at the end of treatment in the presence of C/C genotype was higher compared with the same in patients with C/G and G/G genotypes.

Conclusions. Uncontrolled course of BA twice more common in the presence of G/G genotype compared to C/G genotype and tripled compared to the C/C genotype. Increasing doses of  IGCS contributes to significant strengthening of clinical efficacy in the treatment of BA patients with C/C and C/G genotypes compared with G/G genotype. Thus, G/G genotype is associated with lower response to inhaled corticosteroids.

Key words: bronchial asthma, Bcl1 polymorphism, control, treatment.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. van Schayck OC. Global strategies for reducing the burden from asthma General Practice Airways Group. 2013; 22(2): 239-2 43.
  2. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study, Eur.
  3. Gené RJ, Antui JD, Sano F et al. Asthma control in Latin america (LA) and Caribbean (CAR) countries: correlation between asthma control test (ACT), FEV1 and currenttreatment ERS. In: European Respiratory Society conference, 2009. Poster 3050.
  4. Pedersen S E, Bateman ED, Bousquet J et al. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate ccombination in the Gaining Optimal Asthma control study. Allergy Clin. Immunol. 2007; 120 (5): 1036 – 1042.
  5. Fenech A, Hall ІР. Pharmacogenetics of asthma.
  6. Puzyireva V P. Genetika bronholegochnyih zabolevaniy: monografiya Pod red. V P Puzyireva, L M Ogorodovoy (gl. red. serii A G Chuchalin). Moskva : Holding «Atmosfera», 2010. 160 s.
  7. Pietras T, Panek M, Tworek D et al. The BclI single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study.
  8. Zhdanova MV, Bogdanova MA, Voytovich AN i dr. Novyie vozmozhnosti prognozirovaniya effektivnosti terapii ingalyatsionnyimi glyukokortikosteroidami u detey s bronhialnoy astmoy. Sovremennyie tehnologii v pediatrii i detskoy hirurgii: mater. VII Ros. kongr. Moskva, 2008, rr. 272.
  9. Zhdanova MV, Voitovich AN, Bogdanova MA et al. Glucocorticoid receptor BclI variant in children with different levels of bronchial asthma severity. 11th International Congress of Human Genetics, Brisbane, Australia, 2006. P. 1298.
  10. Van Rossum EF, Koper JW, van den Beld AW et al. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index.
  11. Panarelli M., Holloway CD, Fraser R et al. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects.
  12. Xiang L, Marshall GD. Glucocorticoid receptor BclI polymorphism associates with immunomodulatory response to stress hormone in human peripheral blood mononuclear cells.
  13. Fleury I, Beaulieu Р, Primeau М et al.  Characterization of the BclI polymorphism in the glucocorticoid receptor gene.
  14. Zhdanova MV, Tikhoniva VS, Voitovich AN et al.   Polymorphisms in the glucocorticoid receptor in children with difficult bronchial asthma.
  15. Corvol H, Nathan N, Charlier C et al. Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis. 
  16. Schwabe K, Vacca G, Dück R, Gillissen A. Glucocorticoid receptor gene polymorphisms and potential association to chronic obstructive pulmonary disease susceptibility and severity.
  17. Cuzzoni E, De Iudicibus S, Bartoli F et al. Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone. Br. J. Clin. Pharmacol. 2012; 73(4): 651–655.

 

DETERMINATION OF COMMITMENT DEGREE AGING PATIENTS TO COMMITMENT TO IMPLEMENT OF DOCTOR'S RECOMMENDATIONS

Authors: Roschupkin А.А.

Pages: 124-128

Abstract


Introduction. The one of problem of modern pharmacotherapy - not accurate or improperly execution of doctor's recommendations was described in this article. It is very important in the treatment of older patients because their drug therapy have a some differences (multiple medical appointments, problems with memory, lack of positive motivation to improve, more frequently side effects etc.). Practical doctor must considered certain objective moments affecting regular and prolonged use of prescription drugs also. That's why the understanding of the problems with the correct execution of prescribing and to identifying ways of their correction will enhance the effectiveness of existing treatments in geriatrics.

Materials and methods. This study was conducted in hospital of World War II invalids, by distributing a questionnaire between hospitalized patients with a wide range of age-related pathology. Based on analysis of the survey questionnaire of 124 elderly patients (72-91 years old) to draw conclusions about the level of compliance in geriatric patients.

Discussion. The results of the study show than in about 90 % of cases the compliance was not be satisfactory. But not in all cases it depends from the patients only. There are many difficulties in the patient-doctors cooperation. A few patients have problem with drugs logistics. The causes of deviations from the strict implementation of medical recommendations received by elderly patients at hospital discharge. Based on the findings the recommendations to improve the relationship doctor - an elderly patient in order to increase the effectiveness of pharmacotherapy was given. All geriatricians must find possibilities and time to explain the need for adherence to medical recommendations during the treatment of oldest and elderly patients.

Keywords: Compliance, pharmacotherapy, elderly patients.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Parahonskiy AP. [Pharmacotherapy of aging  pathients]International Journal of applied and basic research. 2009;5(5):125-126.
  2. Belovol FM, Knyazkova II. [Clinical Pharmacology in geriatrics] . 2012; 1 (25): 50-55.
  3. Yevstigneev SV, Elfimova IA, Ctejka OV [The problem of compliance in the treatment of hypertension in Police Officers. The role of the practical physician in solving this problem] Messenger modern clinical medicine2010;3 (2): 38-43.
  4. Leonova MV, Myasoedova NV. [Practical aspects of the treatment of hypertension: efficacy and compliance] Russian Cardiology Journal.2003; 2(2):55-56.
  5. Morisky DE, Green LW, Levine DM. [Concurrent and predictive validity of a self-reported measure of medication adherence] Med. Care. 1986;.2467–74.
  6. Stegmann OA, Petrova MM, Vyrva PV. [Medical factors determining the compliance of outpatients with chronic heart failure] International Journal of applied and basic research2014;5(5):98-101.

 

URINE BETA-2-MICROGLOBULIN EXCRETION CHANGES IN ESSENTIAL HYPERTENSION

Authors: Sychov R.О.

Pages: 129-136

Abstract


The aim of the present study was to establish clinical, diagnostic and predicted significance of beta-2-microglobulinuria as a marker of renal damage at essential hypertension and to determine the prevalence of increased urinary beta-2-microglobulin excretion in essential hypertension. The level of beta-2-microglobulinuria was measured in a group of 46 patients with essential hypertension (21 women, 25 men) and in 17 healthy subjects (as control group). Subjects with clinically significant accompanying pathology were carefully excluded during the patient’s selection. The urinary albumin and beta-2-microglobulin excretion were determined by immune-enzyme assay. According to protocol of the study, all patients have undergone examination: clinical, laboratory and instrumental studies, including echocardiography, 24-h ambulatory blood pressure monitoring, investigation of renal hemodynamic by ultrasound Doppler and evaluation renal functional reserve, estimate of glomerular filtration rate according to Cockroft-Gault formula. The beta-2-microglobulinuria value in hypertensive patients was statistically increase from that observed in normal controls. All patients with essential hypertension were distributed into two groups: with normal value (<400 µg/l) and hyperbeta-2-microglobulinuria. In the second group were registered significantly more often violation of intrarenal hemodynamic, left ventricular hypertrophy, proteinuria, decrease of glomerular filtration rate. The method of beta-2-microglobulin evaluation has enough high specificity, sensitivity in diagnostic hypertensive nephropathy. We conclude that the increased urinary beta-2-microglobulin excretion in patients with essential hypertension is a significant marker of the hypertensive nephropathy.

Keywords: beta-2-microglobulinuria, renal reserve, hypertension, myocardial remodeling, microalbuminuria.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Zanchetti A, Hansson L, Clement D et al. Benefits and risk of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? JHypertension. 2003;21:797-804.
  2. Almazov VA, Shliakhto EV. [Essential hypertension]. Moscow, 2000. 118 p.
  3. Arutiunov GP, Cherniavskaya TK, Lukicheva TI et al. [Microalbuminuria and the way of its medicamental correction]. Clinical pharmacology and therapy. 1999;3:23-28.
  4. Ruilope LM, Rodicio JL. Renal surrogation in essential hypertension. Clin. Exp. Hypertens. 1999;21(5):609-614.
  5. Valderrabano F, Gomez-Campdera F, Jones E. Hypertension as cause of end-stage renal disease: lessons from international registries. Kidney Int. Suppl. 1998;68:60-66.
  6. Grinstein YI, Shabalin VV. [To the question about index of daily urinary β2-macroglobulin excretion using for kidney functional status assessment in patients with essential hypertension]. Sbornik dokladov III Sibirskoy nauchno-practicheskoi konferencii po aktual’nym voprosam farmakoterapii (kardiologiia) [Proceedings of III Siberian scientific and practical conference regarding actual questions of pharmacotherapy (cardiology)]. Krasnoyarsk, 1998, pp. 53-56.
  7. Preobrazhenskii DV, Marenich FV, Romanova NE. [Microalbuminuria: diagnostic, clinical and prognostic significance]. Russian cardiology journal. 2000;5:49-54.
  8. Caetano EP, Zatz. RТ, Praxedes JN. The clinical diagnosis of hypertensive nephrosclerosis - how reliable is it? Nephrol. Dial. Transplant. 1999;14:288-290.
  9. Epstein M, Parving H, Ruiope LM. Surrogate endpoints and renal protection: focus on microalbuminuria. Blood Pressure. 1997;6(suppl. 2):52-57.
  10. Stephenson JM, Kenny S, Stevens LK et al. Proteinuria and mortality in diabetes: the WHO multinational study of vascular disease in diabetes. Diabet. Med. 1995;12:149-155.
  11. Agewall S, Wikstrand J, Ljungman S et al. Does microalbuminuria predict cardiovascular events in non-diabetic men with treated hypertension? Risk factor international study group. Am. J. Hypertens. 1995;8:337-343.
  12. Gogin EE. [Essential hypertension]. МMedicinePubl., 1997. 400 p.
  13. BekhetinaVALeonovaMVBelousovYuBRakovSS[Comparative assessment of nephroprotective effect of hypotensive medications in patients with essential hypertension]. Russiancardiologyjournal. 1999;2:8-13.
  14. Evsikov EM, Lyusov VA, Baikova OA et al. [The nature of essential hypertension]. Russiancardiologyjournal. 2000;5:4-12.
  15. Nanchikeeva ML, Konechnaya EYa, Bulanov MN et al. [Possibilities of early diagnostics of kidney involvement in patients with essential hypertension]. Те2004;9:29-34.
  16. Andrushko ІІ, Serkova VK, Pentyuk OO. [Microproteinuria as a marker of essential hypertension development and progression]. Materialy regional’noi naukovo-practychnoi konferencii “Arterial’na hypertensia: vyiavlennia, poshyrenist’, dyspanserizatsiya, profilaktyka ta likuvanniia”. [Proceedings of regional scientific and practical conference “Arterial hypertension: detection, prevalence, health survey, prophylaxis and treatment”]. Ivano-Frankivsk, 2003, p. 43.
  17. PoliakovLMPoteriaevaONPaninLE[Enzyme linked immunosorbent assayА-I and В in the urine of patients with nephrotic syndrome]. Voprosy meditsinskoy khimii. 1999;1:18-22.
  18. Bernard AM, Moreau D, Lauwerys R. Comparison of retinol binding protein and b2-microglobulin determination in urine for early detection of tubular proteinuria. Clin. Chem. Acta. 1982;126:1-7.
  19. VilchinskayaMYuZharovaEANasonovELRatio of humoral immunity indexes and activity of renin-angiotensin-aldosterone system in patients with essential hypertension. Ter. Arkh. 1991;63(4):54-57.
  20. Abraham PA, Mascioli SR, Launer1994;7:965-974.
  21. Leonova MV, Demidova MA, Tarasov AV, Belousov YuB. [Hypotensive, organoprotective and metabolic efficacy of spirapril in patients with essential hypertension]. Ratsional’naya pharmakoterapia v kardiologii. 2005;2:4-8.
  22. Lavrenova TP. [Urinary enzymes and their importance for the diagnosis of kidney lesions (review of the literature)].
  23. Lukomskaia IS, Lavrenova TP, Tomilina NA, Zubkin ML, Fedorova ND. [Diagnostic value of determining neutral alpha-glucosidase and N-acetyl-beta-D-hexosaminidase activity in the urine in kidney pathology]. Vopr Med Khim. 1986;32(5):112-119.

 

THE PROBIOTIC IN COMPLEX TREATMENT OF CHILDREN WITH ASTHMA

Authors: Smiyan O.I., Kurganska V.A., Romaniuk O.K., Sichnenko P.I., Bynda T.P., Gorbas V.A., Vasylieva E.G.

Pages: 137-145

Abstract


Introduction. Dysbiotic violation of intestinal microflora lead not only to changes in metabolism, but also can be a direct cause of a number of pathologies, including allergic, increase the risk of disease, including bronchial asthma.

The purpose of our study is to determine the effect of probiotic medicine on the condition of the intestinal microflora of children with asthma and indirect - on the immune system and trace element metabolism.

Materials and Methods. The study involved 43 children with moderate persistent form of bronchial asthma between the ages of 12 and 18 to identify the influence of probiotic medicine on the state of the biocenosis of the intestine, the immune system and the trace element composition. To determine the condition of the intestinal microbiota performed microbiological examination of excrement for determining species composition and population of microorganisms by the method of Epstein-Litvak RB and Vilshanska FL. The study of the immunological status of children was conducted by determining the level of indicators of cellular and humoral immune system (CD3 +, CD4 +, CD8 +, CD16 +, CD22 +, FI, IgG, IgA, IgM, IgE), and the profile of cytokines (proinflammatory IL-1 and anti-inflammatory IL- 4) in immunological laboratory "Plus Diagnostics" on immunoferment analyzer "ImmunoChem - 2100 MicroplateReader" firm "HighTechnology, Inc." (USA), 2009 model year. The explore of trace-element composition of blood serum was based on the determination of concentrations of Zn, Cu, Mg and Ca by atomic absorption spectrophotometry. Statistical analysis of the results was performed according to the method of variation statistics using licensing program Microsoft Excel 7.0. To estimate the density of communication among the variables have used the correlation coefficient, the significance of which tested for appropriate formula and compared with tabulated (t Student”s test ).

Discussion. The dependence of the normalization of intestinal microbial spectrum not only on the nature of the treatment, in particular the inclusion of complex treatment probiotic preparation " Laktofit " that contains a combination of lactic acid bacteria (Lactobacillus Sporogenes and Bacillus coagulans), Folic acid (vitamin B9 ), and Cyanocobalamin (vitamin B12 ), but also depends on the dose. Administration of a double dose also gave a more pronounced effect on the impact of cellular and humoral immunity, revealed a decrease in the production of proinflammatory cytokines and normalization of the mineral balance in this group of children.

The obtained results gives reason to recommend the inclusion of probiotic preparation in complex therapy of moderate persistent forms of asthma in older children from the first days after hospitalization for acute illness according to this scheme :- 2 capsules 2 times daily with meals for 14 days.

Keywords: children , asthma, probiotic , microbiocenosis intestine, immune system, microelements.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Said HM. Intestinal absorption of water-soluble vitamins in health and disease2011;37(3):357-372.
  2. PiletskyiAM. [Correction of intestinal microbiota in patients with bronchial asthma combined with chronic fatigue syndrome]Bykovinskyi Meduchnyi Visnuk. 2010;14(3):42-44
  3. SmiyanOISluvaVVMoshchuchOP. [State of intestinal microbiota and evaluation of application Laktovit Forte in acute obstructive bronchitis in infants]. J. Zdorovia Rebenka.2011;35(8):37 – 43.
  4. SmiyanOIKurganskaVOMoshchuchOP[The content of proinflammatory and anti-inflammatory cytokines in the blood serum of children with asthma of varying severity].2012;39(9):35 – 38.
  5. SmiyanOIKurganskaVOMoshchuchOP[Concentration of zinc, copper, magnesium and calcium in blood serum of children with asthma, and its dependence on the severity of the disease] 2011;73(5):7 – 12 .
  6. Stearns JC, Lynch MD, Senadheera. Sci Rep. 2011. 170 p.
  7. Frick JS. The Gut Microflora and Its Variety of Roles in Health and DiseaseCurr Top Microbiol Immunol.2012; 5:112-124.
  8. AntupkinYG. [Current views on etiopathogenesis, clinical, diagnostic and medical peculiarities of inflammation in non-specific respiratory diseases in children].2011;45(1):18-23.
  9. The Order of the Ministry of Health of Ukraine from Pro zatverdgenia protokoliv diagnostiku ta likuvania alergologichnuch chvorob u ditej. [On Approval of the protocols for diagnosis and treatment of allergic diseases in children].
  10. Epstein-Litvak RV, Vylshanskaya FLBakteriologicheskaia diagnostika kishechnika. [Bacteriological Diagnostics of intestinal].  Guidelines. М;1977.23 p.

 

MICRORHEOLOGY OF BLOOD IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN COMBINATION WITH ISCHEMIC HEART DISEASE

Authors: Shuper S.V.

Pages: 146-152

Abstract


Introduction. Comorbidity of Chronic Obstructive Pulmonary Disease (COPD) with Ischemic Heart Disease (IHD) is one of the important problems of the modern pulmonology. Microcirculatory disorders are the common pathogenic links of both diseases.

The aim of this work was to study the state of aggregation capacity of platelets in patients with a combination of COPD with IHD and to identify possible ways of its correction.

Materials and methods. 32 patients in average age (54,4 ± 3,1) years with a combination of exacerbation of COPD (clinical group B, GOLD II), combined with ischemic heart disease (stable angina pectoris, II functional class) - main group - were studied. 25 patients with exacerbation of COPD (comparison group I) and 27 with ischemic heart disease, stable angina pectoris, II functional class (comparison group II) were included in the comparison groups. Diagnoses of COPD and IHD, the volume of their treatment was determined in accordance with existing protocols. The state of spontaneous and ADP-induced platelet aggregation was studied in those patients.

The results of the study. All indicators of spontaneous and ADP-induced aggregating ability of platelets in patients of the main group were increased in comparing to the norm and parameters of the patients from the comparison group I. Indicators of the aggregating ability of platelets of patients from the comparison group I were multidirectional. Aggregation capacity of platelets in patients of comparison group II was high, but lower than in the main group. Increasing of the aggregation capacity of platelets in patients with a combination of COPD and IHD indicates an increased risk of complications due to the formation of the syndrome of hypercoagulability and requires selection of rational correction.

Keywords: COPD, ischemic heart disease, platelet aggregation.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

  1. Kovalenko, V.М. Коmоrbidnist’ i shlyahy ratsionalnoi pharmacoterapii v revmatologii: dumka specialista [Text] / V.М. Коvalenkо // Ukr. revmatol. zhurn. – 2014. – № 2. – S. 12-13.
  2. Feschenko Ju.I. Khronicheskoje obstruktivnoje zabolevanije legkikh – аktualnaja medico-socialnaja problema [Text] / Ju.I. Feschenko // Ukr. pulmonol. zhurn. – 2011. – № 2. – S. 6-10.
  3. Yashina L.А. Operezhaja COPD na shag / L.A. Yashinа, Т.А. Pertseva, N.N. Ostrovskii [Text] // Zdorovja Ukraini. – 2012. – № 4 (20). – S. 8-10.
  4. Gostri kuty kvadrata: konsultativna rada [Text] / Ju.М. Моstovoj, Т.V. Коnstantinovich, L.V. Rasputina [et.al.] // Zdorovja Ukraini. – 2014. – № 2 (26). – S. 19-21.
  5. Gavrisiuk V.К. Klinicheskaja klassifikacija dykhatelnikh i hemodinamicheskikh  narushenij pri zabolevanijakh legkikh [Text] / V.К. Gavrisiuk // Liky Ukraine. – 2004. – № 11 (88). – S. 29–31.
  6. Buriachkovskaja, L.I. Aktivacija trombocitov i markery vospalenija u bolnikh         ishemicheskoj bolezniu serdtsa s depressiej ST [Text] / L.I. Buriachkovskaja, Е.О. Poliakova, А.V. Zorin [et al.]  // Теrapevt. аrkhiv. – 2006. –  № 10. – S. 9-14.
  7. Paleev N.R. Reologicheskije svoistva krovi u bolnykh khronicheskimi nespecificheskimi zabolevanijami legkikh [Text] / H.R. Palееv, V.I. Каrandashov, V.А. Zhoмоv // Кlin. меd. – 2002. – № 6. – S. 25–28.
  8. Gumeniuk, N.I. Vlijanije оdnokratnоj infuzii reosorbilacta nа pokazateli viazkosti krovi u bolnikh khronicheskim obstructivnim zabolevanijem legkikh [Тext] / N.I. Gumeniuk, N.D. Моrskaja, А.Ja. Dz’ublik // Ukr. pulmonol. zhurn. – 2008. – № 3 (dodatok). – S. 109.
  9. Ambrose, J.A.  New Paradigm for Plaque Stabilization [Text] / Ambrose J.A., Martinez E.E // Circulation. – 2002. – № 105. – Р. 2000-2004.
  10. Marquis K. Cardiovascular manifestations in patients with COPD [Тext] // Rev. Mal. Respir. – 2008. – Vol. 25, № 6. – P. 663-673.
  11. Reologicheskije svoistvа krovi i tiazhest’ dykhatelnoj nedostatochnosti pri obostrenii khronicheskogo obstructivnogo bronchita (СOB) [Тext] / А.V. Lutаj, E.G. Efimova, V. А. Bobkov [et al.] // Sbornik rez’ume ХІ Natsionalnogo kongressа po bolezniam organov dykhanija. – Moskow, 2001. – S. 104.

 

THYMUS IN CHILD IN NORMAL CONDITION AND PATHOLOGY

Authors: Smiyan O.I., Plakhuta V.A., Vasileva E.G., Emets A.М.

Pages: 153-162

Abstract


The article is devoted to the questions of development and functioning of the thymus, its importance in normal and pathological conditions. The data of embryogenesis and pathomorphology of thymus in infants according to domestic and foreign literature were covering in the article. Analysis of worldwide research over the past decade about the relevance of the study of the pathology of the thymus in children pre-preschool age, its prevalence, the value for the normal development of the child's body and the ability to adequate immune response in pathological conditions was conducted. Main stages of development of the thymus are defined in the article. It were presented different views on its formation and structure. The formation of the thymus as neuroendocrine and immune organ is described in detail. Information about the dimensions and the further formation of the thymus in infants and older children analyzed. The main stages of age and accidental involution of the glands and their significance for the organism were described in the article.  Later in the article deals about the importance of the thymus in the development and adequate functioning of the immune system, the implementation of the endocrine function of the gland and its ability to produce a variety of biologically active substances that play a key role not only in immunological, but also in other physiological processes in the body.

Key words: thymus, children, immunity, thymomegaly.

This email address is being protected from spambots. You need JavaScript enabled to view it.

The full text

To view the full text

References

1. Vlasova E. V. Narusheniya protivoinfektsionnoy zaschityi u detey na rannih etapah ontogeneza. Chelyabinsk: 2005. 156 p.

2. Savino W. Neuroendocrine control of thymus physiology. J. Virol. 09/2004; 21(4):412-43.

3. Kurbanov T.G. Fiziologiya i patologiya vilochkovoy zhelezyi. Baku: Azerbaydzh. gos. iz - vo, 1983. 154 p.

4. Tyazhkaya A.V. Problemyi timomegalii u detey. Zhurnal prakticheskogo vracha. 1997; 5:13-15.

5. Weil-Olivier C. Community acquired pneumonia in children. Rev. Part. 2003; Vol.15, 53(13):1428-1433.

6. Kuzmenko L.G. Otsenka velichinyi vilochkovoy zhelezyi u detey pervyih dvuh let zhizni po dannyim ultrazvukovogo skanirovaniya. Pediatriya. 2002; 6:22-26.

7. Isroilov R.I. Diagnosticheskie algoritmyi morfologicheskih priznakov vilochkovoy zhelezyi pri razvitii razlichnyih zabolevaniy u nedonoshennyih. Na dopomogu praktichnomu likarevi. 2003; 4:87-90.

8. Zabrodin, V. A. Sravnitelnyiy analiz involyutsii timusa vzroslogo cheloveka. Morfologiya: Arhiv anatomii, gistologii i embriologii. 2008;133(3):44–45

9. Struchko G.Yu. Morfofunktsionalnoe issledovanie timusa i immunobiohimicheskih pokazateley krovi posle splenektomii i immunokorrektsii. Saransk, 2003: 23 p.

10. Sarilova I.L. Morfofunktsionalnaya harakteristika struktur timusa pri eksperimentalnoy testoktemii: avtoref. dis. kand. med. nauk. Saransk: 2009; 26 p.

11. Breusenko D. V. Stroenie timusa kryis pri vozdeystvii etanola i immunokorrektsii (eksperimentalno-morfologicheskoe issledovanie): avtoref. dis. . kand. med. nauk. Sankt-Peterburg. – 2012: 34 p.

12. Vasendin D. V. Strukturnyie izmeneniya v timuse posle vozdeystviya vyisokoy temperaturyi (eksperimentalnoe issledovanie): avtoref. dis. kand. med. nauk. Novosibirsk: 2009; 128 p.

13. Kulagina N.N. Znachenie ultrazvukovogo issledovaniya v diagnostike timomegalii. Promeneva dIagnostika, promeneva terapIya. 2002; 2:22-25.

14. Karaulov A.V. Klinicheskaya immunologiya i allergologiya: Uchebyu posobie. Meditsinskoe informatsionnoe agenstvo. 2002; 651 p.

15. Labunets I.F. Faktoryi timusa i izmeneniya funktsiy immunnoy i endokrinnoy sistem pri starenii. Problemyi stareniya i dolgoletiya. 2002; 11(2):111-124.

16. Yarilin A.A. Starenie immunnoy sistemyi i timus. Klinicheskaya gerontologiya. 2003; 9(3):8-17.

17. Sallie R. Increased Thymic Output during Acute Measles Virus Infection. J. Virol. 2003; 77(14):7872-7879.

18. Nikolaeva O. Ya. Vliyanie gipotalamicheskih nonapeptidergicheskih faktorov na strukturno-funktsionalnuyu reorganizatsiyu timusa (eksperimentalno-gistologicheskoe issledovanie): dis. . kand. med. nauk. Orenburg. 2004; 176 p.

19. Tokarchuk N. I. MorfofunktsIonalniy stan timusu, gIpofIzarno-tireoYidnoYi sistemi ta optimIzatsIya lIkuvannya dItey rannogo vIku, hvorih na gostru pnevmonIyu. VInnitsya. 2007; 140 p. 20. Arseneva E.P. Gormonalnyiy status u detey s somaticheskimi zabolevaniyami. Voprosyi sovremennoy pediatrii. - 2003. - T.2, Prilozhenie #1.-Materialyi YIII Kongressa pediatrov Rossii «Sovremennyie problemyi profilakticheskoy pediatrii». Moskva: 18-21fevralya, 2003, pp.34-35.

21. Asmolov O.K. Rol gormonIv schitopodIbnoYi zalozi I faktorIv timusa v regulyatsIYi funktsIonalnoYi IntegratsIYi sistem ImunItetu ta gemostazu u hvorih na destruktivnI formi hronIchnih nespetsifIchnih zahvoryuvan legen. Odeskiy medichniy zhurnal. 2004; 2:33-36.

22. Ageeva V. A. Morfologiya timusa rastuschego organizma pri vozdeystvii dozirovannoy gipodinamii i gipokinezii: avtoref. dis. . kand. med. nauk. / V. A. Ageeva. Volgograd. 2007; 147 p.

23. Hlyistova E.S. Karta zaseleniya organov immunnoy sistemyi embriona i ploda cheloveka T- i V-limfotsitami i nachalo endokrinnoy funktsii timusa. Immunologiya. 2002;2:80-82

24. Sibileva E.N. Sindrom uvelicheniya vilochkovoy zhelezyi u detey rannego vozrasta. Pediatriya i neonatologiya. 2008;2:36–47.

25. Petrenko V.M. O morfogenezedoley timusa u plodovbeloy kryisyi. Biologicheskie nauki. Uspehi sovremennogo estestvoznaniya. 2012;11:35-37.

26. Effektivnost alternativnoy immunizatsii (vaktsinatsii) v eksperimente i klinike v zavisimosti ot funktsionalnoy asimmetrii nervnoy i immunnoy system. Zhurnal asimmetriya. 2008;2:4-12.

27. Bashmakov O. A. Mikrotsirkulyatornoe ruslo i sosudisto-tkanevyie vzaimootnosheniya kapsulyi timusa cheloveka v pre- i postnatalnom ontogeneze: avtoref. dis. . kand. med. nauk. Moskva. 2008; 149 p.

28. Belyakov V.A. Adaptatsionnyie vozmozhnosti i zdorove detey rannego vozrasta. Rossiyskiy pediatricheskiy zhurnal. 2005; 2:8-10.

29. Samal T.P. Timomegalii u detey grudnogo vozrasta. Zdravoohranenie respubliki Belarus, Minsk: 2002;9:41-45.

30. Yakobisyak M. Imunologiya / Per. z pol. V.V.Chop’yak. V.: Nova kniga, 2004, 672 p.

31. Senatorova A.S. Taktika nablyudeniya i lechenie detey s vrozhdennyimi porokami serdtsa. Sovremennaya pediatriya. 2006;2:123-125.

32. Tyurin N.A Strukturnyie izmeneniya timusa i immunnyiy status v dinamike oslozhnenogo techeniya ostryih respiratornyih zabolevaniy u detey rannego vozrasta. Detskie infektsii. 2005; 1:25-29

33. Stinich O.A. rol virusno-bakterialnih asotsiatsiy u formuvanni retsidivuyuchih bronhitiv u ditey rannogo viku z sindromom giperplaziyi timusu. Suchasni infektsiyi. 2002; 1:42-48.

34. Ismail Naser Naval Hasan. Pokazateli urovnya syivorotochnoy timicheskoy aktivnosti pupovinnoy krovi novorozhdYonnyih detey: Dis. . kand. med nauk. M., 2003; 16 p.

35. Smirnova B.C. Immunodefitsitnyie sostoyaniya. SPb: Foliant, 2000. 560 p.

36. Samson A. N. Toksoplazmoz: ot ostrogo protsessa k hronicheskomu. Liki Ukrayini. 2005;9:29-32.

37. Uchaykin V.F. Reshennyie i nereshennyie problemyi infektsionnoy patologii u detey. Pediatriya. 2004; 4:4-6.